1. Endocrine System Overview

Key Concepts

ํ˜ธ๋ฅด๋ชฌ์„ ์ƒ์„ฑํ•˜์ง€๋งŒ, ๊ด€ ์—†์ด ํ˜ˆ๋ฅ˜๋ฅผ ํ†ตํ•ด ๋ชธ์— ํ˜ธ๋ฅด๋ชฌ์„ ๋‚ด๋ณด๋‚ธ๋‹ค. (ductless glands that secrete hormones directly into the bloodstream)

์‹œ์ƒํ•˜๋ถ€(Hypothalamus) โ†’ ๋‡Œํ•˜์ˆ˜์ฒด(Adenohypophysis) โ†’ Target endocrine glands (๊ฐ‘์ƒ์ƒ˜, ๋ถ€๊ฐ‘์ƒ์ƒ˜, ๋ถ€์‹  ๋“ฑ)

  • โœ”๏ธ ๊ธฐ๋Šฅ :

    • ์„ฑ์žฅ ์กฐ์ ˆ (regulate growth)
    • ๋Œ€์‚ฌ (metabolism)
    • ์ „ํ•ด์งˆ ๊ท ํ˜• (electrolyte balance) - ๋ถ€๊ฐ‘์ƒ์ƒ˜์€ ์นผ์Š˜ ์ด์˜จ ๋†๋„ ์กฐ์ ˆ์— ์ค‘์š”.
    • +) Reproduction, Stress responses ๋“ฑ
  • โœ”๏ธ Disorders (๋‚ด๋ถ„๋น„ ์‹œ์Šคํ…œ์ด ๋น„์ •์ƒ์ผ ๋•Œ ๋‚˜ํƒ€๋‚˜๋Š” ์ผ) :

    • Hyperfunction (๊ธฐ๋Šฅ์„ ๋„ˆ๋ฌด ๋งŽ์ด), Hypofunction (๊ธฐ๋Šฅ์„ ์ ๊ฒŒ)
    • Endocrine-like syndromes (๋‚ด๋ถ„๋น„ ์œ ์‚ฌ ์ฆํ›„๊ตฐ -e.g., ectopic hormone production - ์—‰๋šฑํ•œ ๋ฐ์„œ ๋ถ„๋น„, ๋‹ค๋ฅธ ๋ฌผ์งˆ์ด ํ˜ธ๋ฅด๋ชฌ ํ‰๋‚ด)

Endocrine Dysfunction

์ƒ˜ ์ž์ฒด์˜ ๋ฌธ์ œ๋ƒ, ๋” ์ƒ์œ„ ๊ธฐ๊ด€์˜ ๋ฌธ์ œ๋ƒ์— ๋”ฐ๋ผ primary์™€ secondary๋กœ ๊ตฌ๋ถ„ํ•œ๋‹ค. (Primary Hypofunction / Secondary Hypofunction / Primary hypofunction / Primary Hyperfunction)

1) Primary Hypofunction
  • Canine lymphocytic thyroiditis :
    • ๊ฐœ์—์„œ๋Š” ์ž๊ฐ€๋ฉด์—ญ์„ฑ ๊ฐ‘์ƒ์„ ์—ผ์ด ๊ฐ€์žฅ ์œ ๋ช…ํ•˜๋‹ค.
    • ๊ฐ‘์ƒ์„ ์— lymphocyte๊ฐ€ ๋ฉด์—ญ๋ฐ˜์‘์„ ์ผ์œผ์ผœ ๊ฐ‘์ƒ์„ ์˜ ์‹ค์งˆ์ด ๋‹ค ํŒŒ๊ดด๋œ๋‹ค. (โ†’ T3, T4 ๋ถ„๋น„ ๊ฐ์†Œ)
  • Canine Addisonโ€™s disease :
    • ๋ถ€์‹ ์— ์ž๊ฐ€๋ฉด์—ญ์ด ๋ฐœ์ƒํ•ด ํ”ผ์งˆ ๋ถ€๋ถ„์ด ํŒŒ๊ดด๋œ๋‹ค. โ†’ ๋ถ€์‹  ๋ถ„๋น„ ํ˜ธ๋ฅด๋ชฌ ๊ฐ์†Œ
  • Juvenile panhypopituitarism :
    • ์ €๋จผ ์…ฐํผ๋“œ์—์„œ ๋งŽ์€ ์œ ์ „ ์งˆํ™˜.
    • ๋ฏธ์„ฑ์ˆ™ํ•œ(juvenile) ๊ฐœ์ฒด์—์„œ ์ž์ฃผ ๊ด€์ฐฐ๋œ๋‹ค(๋ฐœ์ƒํ•™์  ์ด์ƒ).
    • Pituitary gland๊ฐ€ cyst ํ˜•ํƒœ๋กœ ๊ด€์ฐฐ๋˜๋ฉฐ, ์ „๋ฐ˜์ ์œผ๋กœ ๊ธฐ๋Šฅ์„ ๋ชปํ•ด ์™œ์†Œ์ฆ(proportional dwarfism)์ด ์ƒ๊ธด๋‹ค.
  • ๋ฌด๊ธฐ๋ ฅ(lethargy), ํ—ˆ์•ฝ(weakness) ๋“ฑ ๋น„ํŠน์ด์ ์ธ ์ฆ์ƒ์ด ๋‚˜ํƒ€๋‚œ๋‹ค. (+ํ”ผ๋ถ€ ์งˆํ™˜์ด ๋‚ด๋ถ„๋น„์™€ ๋ฐ€์ ‘ํ•˜๊ฒŒ ์—ฐ๊ด€๋˜๋Š” ํŽธ์ด๋ฉฐ, ๋‚ด๋ถ„๋น„ ๊ณ„ํ†ต์˜ ์ด์ƒ์€ ๋ณดํ†ต ์–‘์ธก์„ฑ์˜ ํƒˆ๋ชจ๋ฅผ ์œ ๋ฐœํ•œ๋‹ค.)
2) Secondary Hypofunction
  • Secondary Adrenocortical Hypofunction :

    ๋ถ€์‹ ํ”ผ์งˆ์ด ๋งค์šฐ ์œ„์ถ•๋˜์–ด ์žˆ๋‹ค. (์ˆ˜์งˆ๊ณผ ํ•œ์ชฝ ํ”ผ์งˆ์˜ ์ •์ƒ ๋น„์œจ์€ 1:1 ๋‡Œ์— ์ƒ๊ธด ์ข…์–‘์œผ๋กœ ์ธํ•ด 2์ฐจ์ ์œผ๋กœ ์œ„์ถ•๋จ.
    • ๋‡Œ์— ์ข…์–‘์ด ์ƒ๊ฒจ ๋‡Œํ•˜์ˆ˜์ฒด์™€ ์‹œ์ƒํ•˜๋ถ€์—์„œ ๋ถ€์‹  ์ž๊ทน ํ˜ธ๋ฅด๋ชฌ์ด ์ œ๋Œ€๋กœ ๋ถ„๋น„๋˜์ง€ ๋ชปํ•จ โ†’ ๋ถ€์‹  ํ”ผ์งˆ ์œ„์ถ• โ†’ ๋ถ€์‹  ํ”ผ์งˆ์—์„œ ๋ถ„๋น„ํ•ด์•ผ ํ•  ํ˜ธ๋ฅด๋ชฌ๋„ ๋ถ„๋น„๋˜์ง€ ๋ชปํ•จ.
    • ๊ทธ๋ž˜์„œ secondary hypofunction์— ํ•ด๋‹นํ•œ๋‹ค.
  • Non-functional Pituitary Macroadenoma : ๋‡Œํ•˜์ˆ˜์ฒด์— ์ข…์–‘์ด ์ƒ๊ธฐ๋ฉด ์ •์ƒ์ ์œผ๋กœ ๋ถ„๋น„ํ•˜๋˜ ACTH๊ฐ€ ์ ์–ด์ง€๊ณ , ์–‘์ชฝ ๋ถ€์‹ ์ด ๋‹ค ์œ„์ถ•๋œ๋‹ค.
    • ์ž„์ƒ์ ์œผ๋กœ๋Š” Addisonโ€™s disease ๊ฐ™์€ primary hypofunction(์›๋ฐœ ์žฅ๊ธฐ์˜ ์†์ƒ)๊ณผ ์œ ์‚ฌํ•ด ๋ณด์ด์ง€๋งŒ, ๊ผญ ์ž๊ฐ€๋ฉด์—ญ์„ฑ์ด ์•„๋‹ ์ˆ˜๋„ ์žˆ๋‹ค๋Š” ๊ฒƒ์„ ๊ธฐ์–ตํ•˜์ž. (์ด ๊ฒฝ์šฐ ๋ณดํ†ต ACTH level์ด ๋‚ฎ๋‹ค!)`
3) Primary Hyperfunction

๋‚ด๋ถ„๋น„ ์žฅ๊ธฐ ์ž์ฒด์˜ ๋ฌธ์ œ๋กœ ๊ธฐ๋Šฅ์ด ํ•ญ์ง„๋˜๋Š” ๊ฒฝ์šฐ. (์ข…์–‘, ๋‹จ์ˆœ ๊ณผ์ฆ์‹ ๋“ฑ)

  • Adrenal adenoma producing cortisol โ†’ Cushingโ€™s disease : ๋ถ€์‹  ํ”ผ์งˆ ๊ธฐ๋Šฅ ํ•ญ์ง„์ฆ
    • ์ฐธ๊ณ ) Iatrogenic Cushing : ์Šคํ…Œ๋กœ์ด๋“œ ์ฒ˜๋ฐฉ์„ ๋„ˆ๋ฌด ๋งŽ์ด ํ–ˆ์„ ๋•Œ 2์ฐจ์ ์œผ๋กœ ๋ฐœ์ƒ
  • Thyroid follicular adenoma in cats โ†’ T3/T4 ๊ณผ๋‹ค ๋ถ„๋น„ โ†’ Hyperthyroidism : ๊ณ ์–‘์ด์—์„œ๋Š” ๊ฐ‘์ƒ์„  ๊ธฐ๋Šฅ ํ•ญ์ง„์ฆ์ด โ†‘
  • Parathyroid chief cell adenoma โ†’ hypercalcemia : ๋ถ€๊ฐ‘์ƒ์„ ์˜ chief cell์ด ์–‘์„ฑ ์ข…์–‘์œผ๋กœ ์ธํ•ด ๊ณผ์ฆ์‹ โ†’ ๋ถ€๊ฐ‘์ƒ์„ ํ˜ธ๋ฅด๋ชฌ์˜ ๊ณผ๋‹ค ๋ถ„๋น„๋กœ ์ธํ•œ ํ˜ˆ์ค‘ ์นผ์Š˜ ๋†๋„ ์ฆ๊ฐ€
  • ์–‘์ธก์„ฑ์œผ๋กœ ์กด์žฌํ•˜๋Š” ๋‚ด๋ถ„๋น„ ์žฅ๊ธฐ์—์„œ๋Š” ํ•œ์ชฝ์ด ๊ณผ์ฆ์‹๋˜๋ฉด โ†’ ํ˜ˆ์ค‘ ํ˜ธ๋ฅด๋ชฌ ๋†๋„๊ฐ€ ์ฆ๊ฐ€ โ†’ ์ƒ์œ„ ๊ธฐ๊ด€์—์„œ ์–ต์ œ์‹ ํ˜ธ (negative feedback loop) โ†’ ๊ณผ์ฆ์‹๋˜์ง€ ์•Š์€ ๋ฐ˜๋Œ€์ชฝ ์žฅ๊ธฐ๋Š” ๋Œ€๋ถ€๋ถ„ ์œ„์ถ•๋œ๋‹ค(atrophy of contralateral gland).
4) Secondary Hyperfunction

์ƒ์œ„ ๊ธฐ๊ด€์—์„œ ์ž๊ทน ํ˜ธ๋ฅด๋ชฌ์ด ๊ณผ๋‹ค ๋ถ„๋น„.

  • Pituitary corticotroph adenoma โ†’ โ†‘ ACTH โ†’ bilateral adrenocortical hyperplasia โ†’ hypercortisolemia

    Pituitary corticotroph adenoma โ†’ Bilateral adrenocortical hyperplasia. ์ˆ˜์งˆ์ด ์ •์ƒ๋ณด๋‹ค ํ›จ์”ฌ ์œ„์ถ•๋˜์–ด ์žˆ๋‹ค. ์–‘์ชฝ์ด ๋‹ค ๋‘๊บผ์›Œ์กŒ๋Š”์ง€, ํ•œ์ชฝ์ด ๋‘๊บผ์›Œ์ง€๊ณ  ๋ฐ˜๋Œ€์ชฝ์€ ์–‡์•„์กŒ๋Š”์ง€ ๋ณด๋ฉด primary์™€ secondary๋ฅผ ํŒ๋‹จํ•  ์ˆ˜ ์žˆ๋‹ค. ์ด ๊ฒฝ์šฐ ์–‘์ชฝ ํ”ผ์งˆ์ด ๋‹ค ๋‘๊บผ์›Œ์ง.

    • lactotrophs, thyrotrohs ์— ์ƒ๊ธฐ๋Š” ์ข…์–‘์€ ๋ณดํ†ต ๊ธฐ๋Šฅ์ ์ด์ง€ ์•Š๋‹ค. (corticotrophs์— ์ƒ๊ธด ์ข…์–‘์€ ๋ถ€์‹  ์–‘์ธก์„ ๋‹ค ์ž๊ทนํ•˜๊ฒŒ ๋˜์ง€๋งŒ, ์œ ์ฆ™ ๋ถ„๋น„๋‚˜ ๊ฐ‘์ƒ์„ ์„ ์ž๊ทนํ•˜๋Š” ์ชฝ์— ์ƒ๊ธด ์ข…์–‘์€ ํƒ€๊ฒŸ ์žฅ๊ธฐ์˜ ๋น„ํ›„๋ฅผ ๋ณ„๋กœ ์œ ๋ฐœํ•˜์ง€ ์•Š๋Š”๋‹ค.) ์ฆ‰ ๋‡Œํ•˜์ˆ˜์ฒด์— ์˜ํ•ด ๋ถ€์‹ ์ด ๋‘๊บผ์›Œ์ง€๋Š” ๊ฒฝ์šฐ๋Š” ๋งŽ์€ ๋ฐ˜๋ฉด ๊ฐ‘์ƒ์„ ์€ ๊ทธ๋ ‡์ง€ ์•Š๋‹ค.
5) Hormone Resistance & Receptor Failure
  • ๋น„๋งŒ์ธ ๊ฐœ์ฒด๋“ค์€ ์ธ์А๋ฆฐ ์ €ํ•ญ์„ฑ์„ ๊ฐ–๊ธฐ ์‰ฝ๋‹ค โ†’ ๋‹น๋‡จ๊ฐ€ ๋ฐœ์ƒํ•˜๊ธฐ ์‰ฝ๋‹ค. (hyperglycemia despite hyperinsulinemia)
    • ์ œ2ํ˜• ๋‹น๋‡จ - ํ˜ธ๋ฅด๋ชฌ์€ ์ •์ƒ์ ์œผ๋กœ ๋ถ„๋น„๋˜์ง€๋งŒ ํ˜ธ๋ฅด๋ชฌ์— ๋ฐ˜์‘ํ•˜์ง€ ์•Š์•„์„œ ์ƒ๊ธฐ๋Š” ๊ธฐ๋Šฅ ์ด์ƒ. ์‚ฌ๋žŒ์—์„œ ์•Œ๋ ค์ง„ ๋ฐ”๋กœ๋Š”, ์ธ์А๋ฆฐ recptor๊ฐ€ ์ •์ƒ์ ์œผ๋กœ ๋งŒ๋“ค์–ด์ง€์ง€ ์•Š์•„์„œ ๊ทธ๋ ‡๋‹ค. ํ•˜์ง€๋งŒ ์ˆ˜์˜ํ•™์—์„œ ์ด๊ฑด ๋“œ๋ฌผ๊ณ , ์ž˜ ์•Œ๋ ค์ ธ ์žˆ์ง€๋Š” ์•Š๋‹ค.
6) Ectopic Hormone Production
  • ์ข…์–‘์ด ectopic hormone์„ ๋ถ„๋น„ํ•ด์„œ ์›๋ž˜ ๊ทธ ํ˜ธ๋ฅด๋ชฌ์„ ๋ถ„๋น„ํ•ด์•ผ ํ•  ์žฅ๊ธฐ์˜ ๊ธฐ๋Šฅ์„ ๋Œ€์ฒดํ•ด๋ฒ„๋ฆฐ๋‹ค.
  • ํ•ญ๋ฌธ๋‚ญ์— ์ƒ๊ธฐ๋Š” ์•…์„ฑ ์ข…์–‘(Apocrine gland carcinoma of the anal sac in dogs) ๋˜๋Š” lymphoma : PTHrP(parathyroid hormone related peptiode) ๋ถ„๋น„ โ†’ ๋น„์ •์ƒ์ ์œผ๋กœ ๊ณ„์† ์นผ์Š˜์„ ๋ถ„๋น„ํ•˜๋„๋ก ์ž๊ทน โ†’ humoral hypercalcemia of malignancy (์ด ํ‘œํ˜„ ์ž์ฒด๋ฅผ ์ดํ•ดํ•˜๊ณ  ์•Œ์•„๋†”์•ผ ํ•œ๋‹ค)

2. ๋‚ด๋ถ„๋น„ ์žฅ๊ธฐ๋ณ„ ์ด์ƒ

1๏ธโƒฃ Pituitary Gland (๋‡Œํ•˜์ˆ˜์ฒด)

Normal Anatomy & Fuction


Pituitary Gland and Hypothalamus. ๋‡Œํ•˜์ˆ˜์ฒด ์ „์—ฝ์€ ์ƒ˜๋‡Œํ•˜์ˆ˜์ฒด(adenohypophysis), ๋‡Œํ•˜์ˆ˜์ฒด ํ›„์—ฝ์€ ์‹ ๊ฒฝ๋‡Œํ•˜์ˆ˜์ฒด(neurohypophysis)๋ผ๊ณ  ํ•œ๋‹ค.

Adenohypophysis (anterior pituitary)ACTH, TSH, GH, LH, FSH, PRL
Neurohypophysis (posterior pituitary)ADH, oxytocin
  • ๊ธฐ๋Šฅ์ ์œผ๋กœ๋Š” adenohypophysis / neurohypophysis
    • Adenohypophysis : ๋Œ€๋ถ€๋ถ„์˜ stimulation ํ˜ธ๋ฅด๋ชฌ์€ ์—ฌ๊ธฐ์„œ ์ƒ์„ฑ๋œ๋‹ค. (ACTH, TSH, GH, LH, FSH, PRL)
    • Neurohypophysis : ํ˜ธ๋ฅด๋ชฌ์„ ๋งŒ๋“ค์ง€ ์•Š๊ณ , ADH์™€ oxytocin์„ ์ €์žฅํ–ˆ๋‹ค๊ฐ€ ๋ถ„๋น„ํ•˜๋Š” ์—ญํ• ๋งŒ! (์‹œ์ƒํ•˜๋ถ€์—์„œ ์ƒ์„ฑ)
  • ๊ตฌ์กฐ์ ์œผ๋กœ๋Š” pars distalis / pars intermedia / pars nervosa

    ๋‡Œํ•˜์ˆ˜์ฒด์˜ ์กฐ์งํ•™์  ๊ตฌ๋ถ„์— ๋Œ€ํ•œ ๋ณด์ถฉ ์ž๋ฃŒ. (์ˆ˜์—… ๋‚ด์šฉX)
  • anterior pituitary์˜ ์„ธํฌ๋“ค์€ ์ƒ์„ฑํ•˜๋Š” ํ˜ธ๋ฅด๋ชฌ์˜ ์ข…๋ฅ˜์— ๋”ฐ๋ผ ์ด๋ฆ„์„ ๋ถ€๋ฅด๊ธฐ๋„ ํ•œ๋‹ค. (ex- growth hormone์„ ์ƒ์„ฑํ•˜๋Š” โ€œsomatotrophsโ€, ACTH๋ฅผ ์ƒ์„ฑํ•˜๋Š” โ€œcorticotrophsโ€ ๋“ฑ)
1.1 Pituitary Cyst and Dwarfism (Juvenile-onset panhypopituitarism)
  • ์ฒญ์†Œ๋…„๊ธฐ, ์ฆ‰ ์„ฑ์ฒด๊ฐ€ ๋˜๊ธฐ ์ „์— ๋ฐœํ˜„๋œ๋‹ค. German Shepherds๊ฐ€ ๋Œ€ํ‘œ์ ์œผ๋กœ ์˜ํ–ฅ์„ ๋ฐ›๋Š”๋‹ค.
  • Proportional dwarfism, alopecia, delayed dentition ๋“ฑ ์ „์ฒด์ ์œผ๋กœ ์‹ ์ฒด์˜ ์„ฑ์žฅ์ด ์–ต์ œ๋œ๋‹ค.
    • โ€˜๋น„์œจ์ ์œผ๋กœโ€™ ์ฆ‰ ์ „์ฒด์ ์œผ๋กœ ์ž‘์•„์ง„๋‹ค. (ํŠน์ • ๋ถ€์œ„๊ฐ€ ์ž‘์•„์ง€๋Š” ๊ฒŒ ์•„๋‹ˆ๋ผ ์‹ ์ฒด ์ž์ฒด๊ฐ€ ๋น„์œจ์ ์œผ๋กœ ์ถ•์†Œ๋˜๋Š” ๋А๋‚Œ. โ†” ๋ง๋‹จ ๋น„๋Œ€์ฆ)
    • ํ„ธ๋„ ์ž˜ ์•ˆ ๋‚˜๊ณ  ์น˜์•„ ๋ฐœ๋‹ฌ๋„ ๋А๋ ค์ง„๋‹ค.
  • ๋‡Œํ•˜์ˆ˜์ฒด๊ฐ€ ํ…… ๋นˆ, ๋‚ญ์„ฑ ๊ตฌ์กฐ์ฒ˜๋Ÿผ ๋งŒ๋“ค์–ด์ง€๋Š” ๋ฐœ์ƒํ•™์  ์ด์ƒ โ†’ โ€œpanhypoโ€
  • ์กฐ์งํ•™์ ์œผ๋กœ cycstic dilation์ด ํŠน์ง•์ด๋‹ค.
1.2 PPID (Pituitary Pars Intermedia Dysfunction) in Horse
  • ๋‚˜์ด๋“  ๋ง์—์„œ ํŠน์ง•์ ์œผ๋กœ ๊ด€์ฐฐ๋˜๋Š” ์งˆํ™˜์ด๋‹ค. (์ฟ ์‹ฑ๊ณผ ์ฆ์ƒ์ด ๋น„์Šทํ•ด ๊ณผ๊ฑฐ์—๋Š” โ€˜๋ง์˜ ์ฟ ์‹ฑ ์ฆํ›„๊ตฐโ€™์œผ๋กœ ๋ถˆ๋ ธ์œผ๋‚˜, ํ˜„์žฌ๋Š” ์ฟ ์‹ฑ๊ณผ ๋‹ค๋ฅด๋‹ค๋Š” ๊ฒƒ์ด ๋ฐํ˜€์ ธ ๊ทธ๋ ‡๊ฒŒ ๋งํ•˜์ง€ ์•Š๋Š”๋‹ค.)
  • ์ด๋ฆ„ ๋œป = ๋‡Œํ•˜์ˆ˜์ฒด์˜ Pars Intermedia ๋ถ€๋ถ„์ด ์ œ ๊ธฐ๋Šฅ์„ ํ•˜์ง€ ๋ชปํ•˜๋Š” ์งˆํ™˜.
    • โ€˜dysfunctionโ€™ = ๊ผญ ์ €ํ•˜์ฆ์„ ์˜๋ฏธํ•˜์ง€ ์•Š๋Š”๋‹ค.
    • ์‹œ์ƒํ•˜๋ถ€์—์„œ ๋‚ด๋ ค์™€ pas intermedia๋ฅผ ์–ต์ œํ•˜๋Š” dopaminergic neuron์ด ํ‡ดํ–‰ โ†’ ์ ์ ˆํ•œ ์–ต์ œ๋กœ ์กฐ์ ˆ๋˜์ง€ ๋ชปํ•ด์„œ ๊ณผ๋„ํ•˜๊ฒŒ ๊ธฐ๋Šฅํ•˜๋Š” ์งˆํ™˜.
    • Melanotroph์˜ adenoma/hyperplasia๋ฅผ ์œ ๋ฐœ โ†’ pro-opiomelanocortin(POMC; ACTH ๋“ฑ์˜ ํ˜ธ๋ฅด๋ชฌ ์ „๊ตฌ์ฒด)์˜ overproduction โ†’ ํ˜ธ๋ฅด๋ชฌ ๋ถ„๋น„๊ฐ€ ์ฆ๊ฐ€ํ•œ๋‹ค.
  • ์ž„์ƒ ์ฆ์ƒ :
    • hirsutism(๋‹ค๋ชจ์ฆ) : androgen (๋ถ€์‹ ์—์„œ ๋‚˜์˜ค๋Š” ์„ฑํ˜ธ๋ฅด๋ชฌ) ์ฆ๊ฐ€๋กœ ๋ฐœ์ƒ. ์ด๊ฑด pathognomonic(ํŠน์ง•์ ์ด๊ณ  ์ „ํ˜•์ )ํ•œ ํŠน์ง•์ด๋‹ค. (๋ง์—์„œ ํ˜ˆ์ค‘ ์•ˆ๋“œ๋กœ๊ฒ ๋†๋„๊ฐ€ ๋†’์•„์ ธ ์žˆ์œผ๋ฉด ์ „ํ˜•์ ์œผ๋กœ PPID)
    • laminitis(๋ง๊ตฝ์—ผ), PU/PD, ๊ทผ์œก ์œ„์ถ•, pot belly (์ด๋Ÿฐ ์‹์œผ๋กœ ์ฟ ์‹ฑ๊ณผ ๋น„์Šทํ•œ ํŠน์ง•)
      • โ€œpot bellyโ€ : ๊ทผ์œก์ด ๊ณ„์† ๋ถ„ํ•ด(muscle wasting)๋˜๋ฉด์„œ ๋ณต๊ฐ• ๋‚ด์šฉ๋ฌผ์„ ์žก์•„์ฃผ์ง€ ๋ชปํ•ด ๋‚ด์šฉ๋ฌผ ๊ทธ๋Œ€๋กœ ๋ณต๋ถ€๊ฐ€ ๋ฐ–์œผ๋กœ ๋ณผ๋กํ•˜๊ฒŒ ๋ณด์ธ๋‹ค.
  • ์กฐ์งํ•™์  ํŠน์ง• : melanotropes์˜ ์ฆ์‹์ด ๋‘๋“œ๋Ÿฌ์ง„๋‹ค.


Adenoma์— ์˜ํ•ด ๋น„๋Œ€๋œ ๋ง์˜ pituitary gland. ๋‡Œํ•˜์ˆ˜์ฒด ์ค‘ pars intermedia ๋ถ€๋ถ„์ด ํŠนํžˆ ์ปค์ ธ ์žˆ๋‹ค.

dysfunction = ๊ธฐ๋Šฅ์˜ ์กฐ์ ˆ์ด ๋ฌด๋„ˆ์ง„ ์ƒํƒœ. ๊ผญ ๊ธฐ๋Šฅ์ด ์ €ํ•˜๋œ ๊ฒƒ๋งŒ์€ ์•„๋‹ˆ๋‹ค. PPID๋„ ๊ธฐ๋Šฅ์ด ์กฐ์ ˆ๋˜์ง€ ์•Š๊ณ  ๊ณผ๋„ํ•œ ๊ฒƒ.

1.3 Functional Corticotroph Adenomas in Dogs
  • Corticotrophs(= ACTH producing cells)๋“ค์ด ์–‘์„ฑ์ข…์–‘ํ™”๋œ ๊ฒƒ.
  • Pituitary-dependant hyperadrenocorciticm (Cushingโ€™s disease)์˜ ์ฃผ์š” ์›์ธ์ด๋‹ค. (Pituitary gland์—์„œ ACTH ๊ณผ๋‹ค ๋ถ„๋น„ โ†’ ์–‘์ธก์„ฑ์œผ๋กœ ๋ถ€์‹  ํ”ผ์งˆ์˜ ๋น„๋Œ€)
    • ์ด๋Ÿฐ ๊ฒฝ์šฐ secondary ์ฟ ์‹ฑ์— ํ•ด๋‹นํ•จ. (์ฟ ์‹ฑ์ด๋ผ ํ•ด์„œ corticosteroid์˜ ๋†๋„๋งŒ ๋ณด๋Š” ๊ฒŒ ์•„๋‹ˆ๋ผ ์ƒ์œ„ ACTH ๋†๋„๊นŒ์ง€ ํ™•์ธ ํ•„์š”!)
  • ์†Œ๊ฒฌ : Enlarged adrenal cortices
  • ์ž„์ƒ ์ฆ์ƒ : PU/PD, alopecia, pendulous abdomen, calcinosis cutis(ํ”ผ๋ถ€์— ์นผ์Š˜์ด linearํ•˜๊ฒŒ ์นจ์ฐฉ๋œ ๊ฒƒ, ์ฟ ์‹ฑ์—์„œ๋„ ์ „ํ˜•์ ์œผ๋กœ ๊ด€์ฐฐ ๊ฐ€๋Šฅ)
1.4 Pituitary Macroadenomas
  • pituitary gland์— ํฐ ์ข…์–‘์ด ์ƒ๊ธด ๊ฒƒ, ํ•˜์ง€๋งŒ non-functional (ํ˜ธ๋ฅด๋ชฌ ๋ถ„๋น„์— ์˜ํ–ฅ์„ ์ฃผ์ง€ ์•Š์Œ)
  • ๋‹จ ์ข…์–‘์˜ ๋ถ€ํ”ผ๊ฐ€ ์ปค์ง€๋ฉด์„œ ์ฃผ๋ณ€์„ ์••๋ฐ•ํ•ด์„œ ๋‹ค๋ฅธ ๋ถ€๋ถ„์˜ ๊ธฐ๋Šฅ์„ ๋ฐฉํ•ดํ•œ๋‹ค.
    • Functional tumor โ†’ ํ˜ธ๋ฅด๋ชฌ ๋ถ„๋น„, ํƒ€๊ฒŸ ์žฅ๊ธฐ ์ž๊ทน
    • Non-functional tumor โ†’ ์ฃผ๋ณ€ ์žฅ๊ธฐ๋“ค์˜ ๊ธฐ๋Šฅ์„ ์œ„์ถ•์‹œํ‚ด
  • ์ž„์ƒ ์ฆ์ƒ : blindness (pituitary gland๋Š” optic chiasm์˜ ๋ฐ”๋กœ ๊ทผ์ฒ˜ โ†’ ์‹œ๊ฐ๊ต์ฐจ ๋ถ€๋ถ„์„ ์••๋ฐ•ํ•ด์„œ ์‹œ๊ฐ์„ ์ €ํ•ด), ํ–‰๋™ ๋ณ€ํ™”, ๋ฐœ์ž‘

2๏ธโƒฃ Thyroid gland (๊ฐ‘์ƒ์„ )

Normal Anatomy & Function
  • ๊ธฐ๊ด€์— ์œ„์น˜. (๊ฐœ ๊ธฐ์ค€) 5-8๋ฒˆ ๊ธฐ๊ด€์—ฐ๊ณจ ์–‘์˜†์—, ์ ๊ฐˆ์ƒ‰ ๋‚ฉ์ž‘ํ•œ ๋ชจ์–‘์˜ ๊ฐ‘์ƒ์ƒ˜์ด ์Œ์œผ๋กœ ์กด์žฌํ•œ๋‹ค. (๋ถ€๊ฐ‘์ƒ์ƒ˜์€ ๊ฐ‘์ƒ์ƒ˜ ์•ˆ์ชฝ์— ์•„์ฃผ ์กฐ๊ทธ๋งฃ๊ฒŒ ๋ถ™์–ด์žˆ๋‹ค)
  • ์ˆ˜๋งŽ์€ thyroid follicles๋กœ ๊ตฌ์„ฑ๋œ๋‹ค. - colloid๋ฅผ ๊ฐ€์ง€๋Š” ๋‚ด๊ฐ•์„ follicular epithelium์ด ๋‘˜๋Ÿฌ์‹ธ๊ณ  ์žˆ๋‹ค.
  • T3/T4๋ฅผ ๋ถ„๋น„ํ•˜๋Š” follicular cells์™€, follicle ์ฃผ๋ณ€์˜ C cells(parafollicular cells)๋กœ ๊ตฌ์„ฑ๋œ๋‹ค.
    • calcitonin ๋ฉด์—ญ ์—ผ์ƒ‰ : C cell์— ํŠน์ด์ ์œผ๋กœ ๊ฐˆ์ƒ‰์œผ๋กœ ์—ผ์ƒ‰์‹œํ‚จ๋‹ค.
  • hypothalamic TRH์™€ pituitary TSH์— ์˜ํ•ด ์กฐ์ ˆ๋œ๋‹ค. (TRH โ†’ TSH โ†’ T3/T4 axis)
  • T3/T4์˜ ๊ธฐ๋Šฅ : ๋Œ€์‚ฌ ์†๋„ ์กฐ์ ˆ, ์ฒด์˜จ ์กฐ์ ˆ, ์‹ฌ์žฅ ๋ฐ•๋™ ์กฐ์ ˆ
  • ๊ณผ๋„ํ•˜๊ฒŒ ๋ถ„๋น„๋  ๊ฒฝ์šฐ ์‹œ์ƒํ•˜๋ถ€๋‚˜ ๋‡Œํ•˜์ˆ˜์ฒด๋ฅผ ํ†ตํ•ด negative feedback์„ ๋ฐ›๋Š”๋‹ค.


Thyroid gland anatomy and Hormone regulation.


Regulation of Thyroid Follicular Epithelium - Follicular hyperplasia & Follicular atrophy. (A) TSH๊ฐ€ ๊ณผ๋„ํ•˜๊ฒŒ ๋ถ„๋น„๋˜์–ด ๊ฐ‘์ƒ์„ ์ด ๊ณผ์ฆ์‹. (B) T4๋ฅผ ๊ณผ๋„ํ•˜๊ฒŒ ์˜ค๋žœ ๊ธฐ๊ฐ„ ์ฒ˜๋ฐฉํ•ด์„œ ๊ฐ‘์ƒ์„ ์ด ์œ„์ถ•. ๊ฐ‘์ƒ์„  ๊ธฐ๋Šฅ ํ•ญ์ง„๊ณผ ์ €ํ•˜๊ฐ€ ์กฐ์งํ•™์ ์œผ๋กœ๋Š” ์–ด๋–ป๊ฒŒ ํ™•์ธ๋˜๋Š”์ง€ ์•Œ์•„๋‘์ž.

๊ฐ‘์ƒ์„  ๊ธฐ๋Šฅ ์ €ํ•˜๋ฅผ ์œ ๋ฐœํ•˜๋Š” ๋Œ€ํ‘œ์ ์ธ ์›์ธ์€ ๋ฉด์—ญ๋งค๊ฐœ์„ฑ ์—ผ์ฆ.

2.1 Goiter: Hyperthyroidism

ํ•ญ์ƒ ๊ธฐ๋Šฅ์  ํ•ญ์ง„, ๊ธฐ๋Šฅ์  ์ €ํ•˜๋ฅผ ์˜๋ฏธํ•˜์ง„ ์•Š๋Š”๋‹ค. โ€œgoiterโ€๋Š” ํ˜•ํƒœํ•™์  ๋ณ€ํ™”๋ฅผ ์นญํ•˜๋Š” ์šฉ์–ด๋‹ค.

  • ์ •์˜ : ๊ฐ‘์ƒ์ƒ˜์˜ ๋น„์ข…์–‘์„ฑ, ๋น„์—ผ์ฆ์„ฑ ๋น„๋Œ€ (Non-neoplastic, non-inflammatory enlargement) โ†’ ์ƒํ™ฉ์— ๋”ฐ๋ผ ํ•ญ์ง„๋  ์ˆ˜๋„, ์ €ํ•˜๋  ์ˆ˜๋„ ์žˆ๋‹ค.
  • ์›์ธ : iodine์˜ ๊ฒฐํ• ๋˜๋Š” ๊ณผ๋‹ค, goitrogens, dyshormonogenesis(์„ ์ฒœ์ , ํ˜•ํƒœ์  ์ด์ƒ)
  • ๋ฐ˜์ถ”๋™๋ฌผ์—์„œ ๋งŽ์ด ๊ด€์ฐฐ๋œ๋‹ค. + iodine์ด ๊ฒฐํ•๋œ ์ง€์—ญ์—์„œ ํŠนํžˆ ๋งŽ์ด ๋‚˜ํƒ€๋‚œ๋‹ค.
  • ์กฐ์งํ•™์  ๊ตฌ๋ถ„ : Hyperplastic (๊ณผ์ฆ์‹์„ฑ) / Colloid / Congenital dyshormonogenetic / Involutionary
  • ์ฆ์ƒ : ํ—ˆ์•ฝ, ์ฒด์˜จ์กฐ์ ˆ โ†“, ๋ฌด๊ธฐ๋ ฅ, ํƒˆ๋ชจ, ์กฐ์‚ฐ ๋“ฑ (๋‚ด๋ถ„๋น„๊ณ„ ์งˆํ™˜์€ ๋Œ€๋ถ€๋ถ„~)


Iodine-Deficiency (A) โ†’ Colloid goiter (C). (A) Iodine (๊ฐ‘์ƒ์„ ํ˜ธ๋ฅด๋ชฌ ์ƒ์„ฑ์— ์ค‘์š”) ๋ถ€์กฑ โ†’ T3, T4 ๋ถ€์กฑ โ†’ (negative feedback) ๋‡Œํ•˜์ˆ˜์ฒด์—์„œ ๊ฐ‘์ƒ์„  ์ž๊ทน โ†‘ โ†’ ๊ฐ‘์ƒ์„ ์˜ TSH ๋ถ„๋น„ ์ฆ๊ฐ€ โ†’ ๊ฐ‘์ƒ์„ ์˜ follicular cell ์ฆ๊ฐ€ โ†’ ๋ถˆ๊ทธ์Šค๋ฆ„ํ•˜๊ณ  ์ปค์ง„๋‹ค. (B) goiter ์žˆ์Œ, ํƒˆ๋ชจ(๋งค๋ˆ๋งค๋ˆํ•œ ํ”ผ๋ถ€), ์ฃผ๋‘ฅ์ด ๋ถ€๊ทผ์˜ myxedema(์ „์‹  ๋ถ€์ข…์„ฑ ๋ณ‘๋ณ€) (C) ์—ฌ๊ธฐ์„œ iodine ๊ฒฐํ• ์ƒํƒœ๋ฅผ ๊ต์ •ํ•ด์ฃผ๋ฉด colloid ์ƒํƒœ๋กœ ์ „ํ™˜๋  ์ˆ˜ ์žˆ๋‹ค. ํ˜ˆ๊ด€ํ™”๊ฐ€ ์ค„์–ด๋“ค๊ณ , ์„ธํฌ์˜ ์ˆ˜๊ฐ€ ๋งŽ์•„์ง€๊ธฐ๋ณด๋‹จ ๋‚ด๊ฐ•์˜ colloid๊ฐ€ ๋” ์ถ•์ ๋˜๋ฉด์„œ ์ƒ‰์ด ์กฐ๊ธˆ ๋” ์ฐฝ๋ฐฑํ•œ ์ƒ‰์œผ๋กœ ๋ณ€ํ•œ๋‹ค.

Hyperthyroidism ์ธ๋ฐ, ๊ฐ‘์ƒ์„  ๋น„๋Œ€๊ฐ€ ๋‚˜ํƒ€๋‚œ ๊ฒƒ์ด์ง€ ๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ์ด ์ฆ๊ฐ€ํ•œ ๊ฒƒ์€ ์•„๋‹ˆ๋‹ค. goiter์—์„œ๋Š” ํ˜ธ๋ฅด๋ชฌ ๊ณผ๋ถ„๋น„๋ฅผ ์˜๋ฏธํ•˜๋Š” ๊ฒŒ ์•„๋‹˜์„ ๊ธฐ์–ตํ•˜์ž.

In cats

๊ณ ์–‘์ด์—์„œ์˜ ๊ฐ‘์ƒ์„  ๊ธฐ๋Šฅ ํ•ญ์ง„์ฆ์„ ๋ณด์ž. (๊ฐœ์—์„œ๋Š” ๊ฐ‘์ƒ์„ ๊ธฐ๋Šฅ์ €ํ•˜์ฆ, ๊ณ ์–‘์ด์—์„œ๋Š” ๊ฐ‘์ƒ์„ ๊ธฐ๋Šฅํ•ญ์ง„์ฆ์ด ๋งŽ๋‹ค.) Pasted image 20260612135347.png Funtionalํ•œ ์„ธํฌ ๊ณผ์ฆ์‹์„ ์ฃผ์š” ์›์ธ์œผ๋กœ ๋ณธ๋‹ค.

2.2 Canine Hypothyroidism

๊ฐœ์—์„œ๋Š” ๊ฐ‘์ƒ์„  ๊ธฐ๋Šฅ ์ €ํ•˜์ฆ์ด ํ”ํ•˜๋‹ค.

  • ๊ฐœ์—์„œ ๊ฐ€์žฅ ํ”ํ•œ ๋‚ด๋ถ„๋น„ ์งˆํ™˜ ์ค‘ ํ•˜๋‚˜, ๋Œ€๋ถ€๋ถ„ ์ž๊ฐ€๋ฉด์—ญ์„ฑ์œผ๋กœ ๋‚˜ํƒ€๋‚œ๋‹ค.

  • ์›์ธ (์กฐ์งํ•™์  ๋ถ„๋ฅ˜) :

    • (1) Lymphocytic thyroiditis (๋ฆผํ”„๊ตฌ์„ฑ ๊ฐ‘์ƒ์„ ์—ผ - lymphocyte, plasma cell ๋“ฑ์ด ์นจ์œค) : ์ž๊ฐ€๋ฉด์—ญ์— ์˜ํ•ด ๋™์›๋œ ๋ฉด์—ญ์„ธํฌ๋“ค์ด ๊ฐ‘์ƒ์„ ์˜ follicle์„ ํŒŒ๊ดด โ†’ ์œ„์ถ•๋œ follicles ์‚ฌ์ด์˜ ๊ฐ„์งˆ์กฐ์ง์— fibrosis๊ฐ€ ์ƒ๊ธด๋‹ค.
    • (2) Idiopathic atrophy : ์›์ธ์€ ์ •ํ™•ํžˆ ๋ชจ๋ฅด๋‚˜, follicle์ด ์žˆ์–ด์•ผ ํ•  ๊ฐ‘์ƒ์„  ์‹ค์งˆ์ด ์ง€๋ฐฉ์กฐ์ง์œผ๋กœ ๋Œ€์ฒด๋˜๋Š” ๊ฒฝ์šฐ. ๊ฐ‘์ƒ์„ ์˜ ์œ„์ถ•์ด ๊ด€์ฐฐ๋œ๋‹ค.
    • ๊ฐ‘๊ธฐ์ €๋ฅผ ์ผ์œผํ‚ค๋Š” ์ฃผ์š” ์›์ธ์ด์ง€๋งŒ (1)์ด ๊ฐ€์žฅ ํ”ํ•˜๋‹ค.
  • ๊ฒฐ๊ณผ : ๋ณด์ƒ์„ฑ ์ธก๋ฉด์—์„œ TSH ์ฆ๊ฐ€

  • ๋ฌด๊ธฐ๋ ฅ, ํƒˆ๋ชจ, ๋น„๋งŒ, ๋ถˆ์ž„, ๊ณ ์ง€ํ˜ˆ์ฆ(hyperlipidemia)

  • ํ”ผ๋ถ€ ๋ณ‘๋ณ€์€ ์ฃผ๋กœ bilateral symmetrical

  • (์‚ฌ์ง„) lymphocytes & plasma cell follicle ํ•˜๋‚˜ํ•˜๋‚˜๋Š” ๋‚จ์•„์žˆ๋Š” ํŽธ. / follicle ์ด๋”์ค„์–ด๋“ค๊ณ  ์œ„์ถ• (๋งŒ์„ฑ ์ง„ํ–‰ ์‹œ follicle atrophy + ๊ฐ„์งˆ์— ์นจ์œค๋œ lymphocytes & plasma cells + fibrosis)

๊ณ ์–‘์ด๋Š” hyper ๊ฐ‘๊ธฐํ•ญ! ๊ฐœ๋Š” hypo ๊ฐ‘๊ธฐ์ €! (์ž๊ฐ€๋ฉด์—ญ์„ฑ)

2.3 Feline Hyperthyroidism
  • ์ฃผ๋กœ ๋…ธ๋ น๋ฌ˜์—์„œ ๋ฐœ์ƒ ๋นˆ๋„๊ฐ€ ๋†’๋‹ค. (์›์ธ: iodine ๊ฒฐํ•, ์‹ค๋‚ด ์ƒํ™œ์„ ๋„ˆ๋ฌด ๋งŽ์ด, ๋ฐ”๊นฅ์—์„œ goitrogen ๋…ธ์ถœ / carcinoma์—์„œ ์ƒ๊ธฐ๋Š” ๊ฒฝ์šฐ๋Š” ๊ฑฐ์˜ ์—†์Œ)
  • Follicle์˜ ๊ณผ์ฆ์‹(follicular adenoma or functional adenomatous hyperplasia)์ด ๋Œ€ํ‘œ์ ์ธ ์›์ธ์ด๋ฉฐ, carcinoma์— ์˜ํ•ด ์ƒ๊ธฐ๋Š” ๊ฒฝ์šฐ๋Š” ๋“œ๋ฌผ๋‹ค(์›๋ž˜ ๊ธฐ๋Šฅ์„ ์žƒ์–ด๋ฒ„๋ฆฌ๋ฏ€๋กœ).
    • cf) ๋ถ„ํ™”๋„๊ฐ€ ์–‘ํ˜ธํ•˜๋‹ค (์ฃผ๋กœ ์–‘์„ฑ) = ์›๋ž˜ ์„ธํฌ์™€ ๋‹ฎ์€ ์„ธํฌ๋กœ ์ฆ์‹, ๋ถ„ํ™”๋„๊ฐ€ ๋‚˜์˜๋‹ค (์ฃผ๋กœ ์•…์„ฑ) = ์›๋ž˜ ๊ธฐ๋Šฅ์„ ์žƒ์–ด๋ฒ„๋ฆฐ ์ƒํƒœ.
  • T3/T4์˜ ๊ณผ์ž‰ โ†’ ๋Œ€์‚ฌ๊ฐ€ ๋นจ๋ผ์ง(hypermetabolism) โ†’ ๋งŽ์ด ๋จน๋Š”๋ฐ ์‚ด์ด ๊ณ„์† ๋น ์ง„๋‹ค. (์‹ฌ์žฅ ๋ฐ•๋™๋„ ๋นจ๋ผ์ง€๊ณ , ํ™œ๋™์„ฑ๋„ ๊ณผํ•ด์ง€๋Š”๋ฐ ์‚ด์ด ๊ณ„์† ๋น ์ง„๋‹ค)
  • ์ž„์ƒ ์ฆ์ƒ : ์ฒด์ค‘๊ฐ์†Œ, ๊ณผ์‹(polyphagia), ๊ณผ์ž‰ํ–‰๋™(hyperactivity), ๊ตฌํ† , ๋นˆ๋งฅ(tachycardia), goiter

(์‚ฌ์ง„)

  • ํŠน์ดํ•˜๊ฒŒ ์–‘์ธก์„ฑ์œผ๋กœ ๋‹ค ๊ณผ์ฆ์‹๋œ ๊ฒฝ์šฐ๊ฐ€ ์ข…์ข… ์žˆ๋‹ค (bilateral thyroid enlargement)
  • ์ข…์–‘์„ฑ ์ฆ์‹์„ ํ•œ ๋ถ€๋ถ„์„ ํ™•๋Œ€ํ•ด๋ณด๋ฉด, hyperplasia or adenoma๋กœ follicle์˜ ์ˆซ์ž๊ฐ€ ๋Š˜์–ด๋‚˜๊ณ , ์ƒํ”ผ์„ธํฌ๋กœ๋งŒ ๋‘˜๋Ÿฌ์‹ธ์—ฌ ์žˆ๊ณ  ๋‚ด๊ฐ•์€ ๋งค์šฐ ๋ถˆ๊ทœ์น™ํ•˜๊ฑฐ๋‚˜ ๊ฑฐ์˜ ๋ณด์ด์ง€ ์•Š๋Š”๋‹ค.
  • ์˜ค๋ฅธ์ชฝ์†Œ์—ฝํ™”๋œ ๊ฒŒ ์ข…์–‘. (B)์—์„œ์˜ค๋ฅธ์ชฝ์€ ๊ทธ๋ž˜๋„ ๊ตฌ์กฐ ์œ ์ง€ (C) ๋ถˆ๊ทœ์น™ํ•œ ๋‚ด๊ฐ•, ์ƒํ”ผ์„ธํฌ๋งŒ ๊ณผ์ฆ์‹
2.4 Thyroid Neoplasia
  • Dogs : malignant & non-functional
    • ์–‘์„ฑ/๊ณผ์ฆ์‹๋ณด๋‹ค๋Š” follicular carcinoma๊ฐ€ ํ”ํ•œ๋ฐ, nonfunctionalํ•˜๋‹ค. ๋”ฐ๋ผ์„œ ๊ฐ‘์ƒ์„ ๊ธฐ๋Šฅํ•ญ์ง„์ฆ์„ ์œ ๋ฐœํ•˜์ง€ ์•Š๋Š”๋‹ค. ์นจ์Šต/์ „์ด๊ฐ€ ๊ฐ€๋Šฅํ•˜๋ฏ€๋กœ, ๊ฐ‘์ƒ์„ ์˜ ๊ธฐ๋Šฅ๋ณด๋‹ค๋Š” ์ง„ํ–‰ ์†๋„ / ์ „์ด์—ฌ๋ถ€๋ฅผ ์ž˜ ์‚ดํŽด๋ด์•ผ ํ•œ๋‹ค.
  • Cats : benign & functional
    • ๊ณ ์–‘์ด์—์„œ๋Š” follicular adenoma/hyperplasia๊ฐ€ ๋งŽ๊ณ , hyperthyroidism์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค.
  • ๊ฐœ์™€ ํ™ฉ์†Œ์—์„œ ๋“œ๋ฌผ์ง€๋งŒ C-cell tumors ๊ฐ€ ์ƒ๊ธธ ์ˆ˜ ์žˆ๋‹ค(C cell : follicule ์‚ฌ์ด์‚ฌ์ด ์กด์žฌ, calcitonin ๋ถ„๋น„) โ†’ ์ž„์ƒ ์งˆํ™˜์„ ์œ ๋ฐœํ•˜๋Š”์ง€๋Š” ์•Œ๋ ค์ง„ ๋ฐ”๊ฐ€ ์—†๋‹ค.

(์‚ฌ์ง„/8:24)

(A) Thyroid carcinoma์— ์˜ํ•ด ์ƒ๊ธด ์•…์„ฑ ์ข…์–‘. ํ˜ˆ๊ด€ํ™”๊ฐ€ ๋งค์šฐ ์ž˜ ๋˜์–ด ์žˆ๊ณ , ๊ตญ์†Œ์ ์ธ ์นจ์Šต์„ฑ์„ ๋ณด์ธ๋‹ค. (B) ์กฐ์งํ•™์ ์œผ๋กœ ๋ณด๋ฉด ์•„์ฃผ ์–‡์€ ์„ฌ์œ ์†Œ์„ฑ ๊ฒฐํ•ฉ ์กฐ์ง์œผ๋กœ ๊ตฌํš์ด ๋‚˜๋ˆ„์–ด์ ธ ์žˆ๋‹ค(๋‚ด๋ถ„๋น„๊ณ„ ์ข…์–‘์˜ ํŠน์ง•) ๋‚ด๋ถ„๋น„๊ณ„ ์ข…์–‘์ด ์ƒํ”ผ์„ธํฌ ์ข…์–‘์— ๋น„ํ•ด ์ข€ ๋” ๊ตฌํšํ™”๊ฐ€ ์ž˜ ๋ณด์ด๊ณ , ์ข€ ๋” ๊ณผ๋ฆฝ ์–‘์ƒ์ด๋‹ค.

Thyroid follicular carcinoma. Follicular cell ์œ ๋ž˜์˜ ์•…์„ฑ ์ข…์–‘, ๋‹ค์–‘ํ•œ ํฌ๊ธฐ์˜ nest๋ฅผ ๋งŒ๋“ค๊ณ  ์žˆ๋‹ค(=์–‡์€ ๊ฒฐํ•ฉ์กฐ์ง์— ๋‘˜๋Ÿฌ์‹ธ์—ฌ ๋˜˜๋˜˜ ๋ญ‰์ณ ์žˆ๋Š” ๋ชจ์–‘). ์„ธํฌ์˜ ์„ธํฌ์งˆ์€ ๋Œ€๋ถ€๋ถ„ ๊ณผ๋ฆฝ์–‘์ƒ์„ ๋ ๊ณ  ์žˆ๋‹ค.

  • Thyroglobulin(๊ฐ‘์ƒ์„  ์ƒํ”ผ์„ธํฌ์—์„œ ๋ฐœํ˜„๋˜๋Š” ๋‹จ๋ฐฑ์งˆ)์„ ์—ผ์ƒ‰ โ†’ Thyroid follicle ์œ ๋ž˜์˜ ์•…์„ฑ ์ข…์–‘์ž„์„ ํ™•์ • ์ง„๋‹จ.

3๏ธโƒฃ Parathyroid Gland (๋ถ€๊ฐ‘์ƒ์„ )

Normal Structure & Function
  • ๋ถ€๊ฐ‘์ƒ์„ ์€ PTH(parathyroid hormone)์„ ๋ถ„๋น„ํ•˜๋Š” chief cells๋กœ ๊ตฌ์„ฑ๋œ๋‹ค.
  • ๋ถ€๊ฐ‘์ƒ์„ ์˜ ํ•ต์‹ฌ ๊ธฐ๋Šฅ์€ ํ˜ˆ์ค‘ ์นผ์Š˜ ๋†๋„๋ฅผ ๋†’์ด๋Š” ๊ฒƒ!
    • (1) ๋ผˆ์—์„œ ์นผ์Š˜ ์žฌํก์ˆ˜ ์ฆ๊ฐ€ (osteoclastic bone resorption)
    • (2) ์‹ ์žฅ์—์„œ ์นผ์Š˜ ์žฌํก์ˆ˜ ์ฆ๊ฐ€ (renal calcium reabsorption)
    • (3) ๋น„ํƒ€๋ฏผD ํ™œ์„ฑํ™” โ†’ ์†Œ์žฅ์—์„œ ์นผ์Š˜ ํก์ˆ˜ ์ฆ๊ฐ€ (intestinal calcium uptake)
  • PTH ๋ถ„๋น„๋Š” ํ˜ˆ์ค‘ ์นผ์Š˜ ๋†๋„์— ๋”ฐ๋ฅธ negative feedback๋กœ ์กฐ์ ˆ๋œ๋‹ค. (ํ˜ˆ์ค‘ ์นผ์Š˜ ๋‚ฎ์œผ๋ฉด PTH ์ฆ๊ฐ€)
    • ์ธ์‚ฐ ์ด์˜จ(phosphorus)์˜ ์ฆ๊ฐ€์™€ ๋งž๋ฌผ๋ ค ์ธ์‚ฐํ™”์นผ์Š˜(calcium-phosphorus)์ด ๋งŒ๋“ค์–ด์ง€์ง€ ์•Š๋„๋ก ์กฐ์ ˆํ•œ๋‹ค.
3.1 Primary Hyperparathyroidism

๋ถ€๊ฐ‘์ƒ์„  ์ž์ฒด์— ๋ฌธ์ œ๊ฐ€ ์ƒ๊ธด ๊ฒฝ์šฐ๋กœ, ์ฃผ๋กœ chief cell์˜ ์ข…์–‘์„ฑ ๋ณ€ํ™”์™€ ๊ด€๋ จ.

  • Chief cell adenoma์— ์˜ํ•ด ์ž˜ ๋ฐœ์ƒํ•œ๋‹ค.
  • ๊ฐœ์—์„œ ๋งŽ์ด ๋ฐœ์ƒํ•˜๊ณ , ๋‚˜์ด๊ฐ€ ๋งŽ์„์ˆ˜๋ก ๋ฐœ์ƒ๋ฅ ์ด ๋†’๋‹ค.
  • PTH ๊ณผ๋‹ค ๋ถ„๋น„ โ†’ ์ง€์†์ ์ธ hypercalcemia๊ฐ€ ๋ฐœ์ƒํ•œ๋‹ค. (์นผ์Š˜-์ธ์ด ๊ฒฐํ•ฉ์„ ์ด๋ฃจ๋ฏ€๋กœ ์ด๋•Œ phosphorus๋Š” ์ •์ƒ์ด๊ฑฐ๋‚˜ ๋‚ฎ์„ ์ˆ˜ ์žˆ๋‹ค)
  • ์ž„์ƒ ์ฆ์ƒ : PU/PD, ํ—ˆ์•ฝ, ์นผ์Š˜ ๊ณผ๋‹ค๋กœ ์ธํ•œ ์š”๋กœ๊ฒฐ์„(calcium urolithiasis)
  • ์œก์•ˆ์ ์œผ๋กœ๋Š” ํ•œ์ชฝ ๋ถ€๊ฐ‘์ƒ์„ ์ด ์ปค์ ธ ์žˆ๋‹ค (enlarged parathyroid, unilateral)
  • ์กฐ์งํ•™์ ์œผ๋กœ๋Š” chief cell์ด ์น˜๋ฐ€ํ•œ ์–‘์ƒ์œผ๋กœ ์ฆ์‹ํ•œ๋‹ค.
    • ์ฃผ๋ณ€ ์ •์ƒ ๋ถ€๊ฐ‘์ƒ์ƒ˜ ์กฐ์ง์€ ์ข…์–‘์— ์˜ํ•ด ์••๋ฐ•์„ ๋ฐ›๊ฑฐ๋‚˜, negative feedback์— ์˜ํ•ด ์œ„์ถ•.
  • Primary ๋ฌธ์ œ โ†’ PTH ๋†๋„๋„ ๋†’๊ณ  calcium ๋†๋„๋„ ๋†’๋‹ค. (์„ ์„ ๊ฒฝ๊ณ„๋กœ chief cell adenoma / ์ •์ƒ ์กฐ์ง์˜ ์œ„์ถ•์ด ๋‘˜ ๋‹ค ๊ด€์ฐฐ๋œ๋‹ค.
  • ๋ผˆ๊ฐ€ ์•ฝํ•ด์ง€๊ณ  ๊ณจ๋‹ค๊ณต์ฆ๋„ ์ƒ๊ธฐ๊ธฐ ์‰ฝ๋‹ค.
3.3 Secondary Hyperparathyroidism

์ƒ์œ„ ๊ธฐ๊ด€์˜ ๋ฌธ์ œ๋ณด๋‹ค๋Š” ๊ด€๋ จ ์žฅ๊ธฐ์˜ ๋ฌธ์ œ.

[ Renal Secondary Hyperparathyoridism ]

  • ์‹ ์žฅ ๊ธฐ๋Šฅ ๊ฐ์†Œ โ†’ phosphorus ๋ฐฐ์„ค ๊ฐ์†Œ โ†’ hyperphosphatemia (ํ˜ˆ์ค‘ ์ธ์‚ฐ ๋†๋„ ์ฆ๊ฐ€)
  • ์ธ์‚ฐ-์นผ์Š˜ ๊ฒฐํ•ฉ์œผ๋กœ ํ˜ˆ์ค‘ calcium ์†Œ๋ชจ โ†’ ํ˜ˆ์ค‘์—์„œ๋Š” ์นผ์Š˜์ด ๋ถ€์กฑํ•˜๋‹ค๊ณ  ๋А๊ปด PTH ๋ถ„๋น„
  • ๋งŒ๋“ค์–ด์ง„ ์นผ์Š˜์€ ๋‹ค์‹œ ๋ฐฐ์ถœ๋˜์ง€ ์•Š์€ phosphorus์— ์˜ํ•ด ๊ฒฐํ•ฉ โ†’ PTH๋Š” ๋งŒ์„ฑ์ ์œผ๋กœ ๋†’๊ฒŒ ์œ ์ง€๋œ๋‹ค.
  • ๊ทผ๋ณธ์ ์ธ ๋ฌธ์ œ๋Š” ์‹ ์žฅ์— ์žˆ๋‹ค, ์ธ์ด ๋ฐฐ์ถœ๋˜์ง€ ์•Š์•„์„œ ์ƒ๊ธฐ๋Š” ๋ฌธ์ œ.
  • ๋ถ€๊ฐ‘์ƒ์„ ์ด ์ „๋ฐ˜์ ์œผ๋กœ ๋‹ค ๊ณผ์ฆ์‹ํ•œ๋‹ค.
  • fibrous osteodystrophy๋กœ ์ด์–ด์ง„๋‹ค.
    • (๋ผˆ๊ฐ€ ๊ณ„์† ๊ฐ‰์•„๋จนํžˆ๋ฉด์„œ ๊ทธ ๋ถ€๋ถ„์„ ๋Œ€์ฒดํ•˜๊ธฐ ์œ„ํ•ด fibrous, ํ•˜์ง€๋งŒ ๊ฒฐํ•ฉ์กฐ์ง์œผ๋กœ ๋Œ€์ฒด๋˜๋ฉด ๋ผˆ์˜ ๊ฐ•๋„๋Š” ํ›จ์”ฌ ์•ฝํ•ด์ง„๋‹ค.)
    • ์ด๊ฒƒ์ด ์ƒ์•…์—์„œ ๋งŽ์ด ์ƒ๊ธฐ๋Š”๋ฐ, ๊ณ ๋ฌดํ„ฑ์ฒ˜๋Ÿผ ์•ฝํ•ด์ ธ์„œ โ€œrubber jawโ€

(A) (B) parathyroid์˜ ๊ณผ์ฆ์‹์ด ์ „๋ฐ˜์ ์œผ๋กœ ๊ด€์ฐฐ๋œ๋‹ค. T = thyroid gland, ๊ทธ ๋์— parathyroid gland๊ฐ€ ์žˆ๋Š” ๊ฑด๋ฐ ์—„์ฒญ ๋น„ํ›„๋˜์–ด ์žˆ์Œ.

[ Nutritional Secondary Hyperparathyroidism ]

  • ์˜์–‘์„ฑ์œผ๋กœ ๋‹ค์Œ๊ณผ ๊ฐ™์€ ์ƒํ™ฉ์ผ ๋•Œ ๋‚˜ํƒ€๋‚œ๋‹ค: ์นผ์Š˜ ์„ญ์ทจ ๋ถ€์กฑ, phosphorus ๊ณผ๋‹ค ์„ญ์ทจ, ๋น„ํƒ€๋ฏผ D ๋ถ€์กฑ.
  • ๋ณด์ƒ์„ ์œ„ํ•ด PTH๊ฐ€ ์ฆ๊ฐ€ํ•œ๋‹ค - ์„ฑ์žฅ ์ค‘์ธ ๋ง, ํŒŒ์ถฉ๋ฅ˜, ๋ผ์ง€์—์„œ ์ค‘์š”.
  • ์„ฑ์žฅํ•  ๋•Œ ๋ผˆ์˜ ์ƒ์žฅ์ด ๋งค์šฐ ํ™œ๋ฐœํ•˜๋ฏ€๋กœ calcium-phosphorus ๋ถˆ๊ท ํ˜•์ด ์„ฑ์žฅ์— ์˜ํ–ฅ์„ ๋งŽ์ด ์ค€๋‹ค.
  • ์ž„์ƒ ์ฆ์ƒ : limb deformities(์‚ฌ์ง€ ์ดํ˜•์„ฑ), pathologic fractures(๋ณ‘๋ฆฌํ•™์  ๊ณจ์ ˆ-์นผ์Š˜ ๋ถ€์กฑ์œผ๋กœ ๋ผˆ๊ฐ€ ์•ฝํ™”)
  • ์œก์•ˆ์ ์œผ๋กœ๋Š” ์ „๋ฐ˜์ ์ธ ๊ณจ๊ฒฉ์—์„œ ์นผ์Š˜์ด ๋น ์ง (generalized skeletal demineralization)
  • ์กฐ์งํ•™์ ์œผ๋กœ Parathyroid chief cell hyperplasia, ๊ณจ์กฐ์ง์ด ๊ฒฐํ•ฉ์กฐ์ง์œผ๋กœ ๋Œ€์ฒด๋˜๊ณ  ์„ฑ๊ธฐ๊ฒŒ ํ˜•์„ฑ๋จ(woven bone proliferation with fibrous tissue)
  • ์‹์ด์„ฑ์œผ๋กœ ์นผ์Š˜ ๋†๋„๋ฅผ ๋‚ฎ๊ฒŒ, ํ˜น์€ ์ธ์‚ฐ์„ ๋งŽ์ด ์„ฌ์ทจํ•˜๋ฉด ๊ทน๋ณตํ•˜๊ธฐ ์œ„ํ•ด ๋ถ€๊ฐ‘์ƒ์„ ์ด ๊ณผ์ฆ์‹๋˜๋Š” ๊ฒƒ.
Pseudohyperparathyroidism (Humoral Hypercalcemia of Malignancy)
  • Apocrine gland anal sac adenocarcinoma(dogs), lymphoma(dogs and cats) ๋‘ ๊ฐ€์ง€๋Š” ๋ฐ˜๋“œ์‹œ ์™ธ์›Œ๋‘์ž.
  • PTH ํ˜ธ๋ฅด๋ชฌ ์ž์ฒด๋Š” ๋‚ฎ์•„์ ธ ์žˆ์ง€๋งŒ, ์ข…์–‘์—์„œ ๋ถ„๋น„ํ•˜๋Š” PTH-rP๋กœ ์ธํ•ด ํ˜ˆ์ค‘ ์นผ์Š˜ ๋†๋„๋Š” ํ•ญ์ƒ ๋†’์Œ.
  • ํ˜ˆ์ค‘ ์นผ์Š˜ ๋†๋„์˜ ์ด์ƒ โ†’ ๋‹น๋‡จ, PU/PD, ๋ฌด๊ธฐ๋ ฅ, ๊ตฌํ† , ์‹ฌ์‹ค์„ธ๋™(cardiac arrhythmias)
  • ์‹ฌ๋ฐ•๋™์€ ํ•ญ์ƒ K, Ca, Na 3๊ฐœ์˜ ๊ท ํ˜•์— ์˜ํ•ด ์กฐ์ ˆ โ†’ ๋ถ€์ •๋งฅ์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค.
3.5 Hypoparathyroidism & Parturient hypocalcemia

๋ถ€๊ฐ‘์ƒ์„  ๊ธฐ๋Šฅ ์ €ํ•˜์ฆ : ๊ต‰์žฅํžˆ ๋“œ๋ฌผ์ง€๋งŒ ์–ด์จŒ๋“  ์žˆ๋‹ค.

  • ๋“œ๋ฌผ๊ฒŒ ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ๋Š” ์ด์œ ๋กœ๋Š” ๋ฉด์—ญ๋งค๊ฐœ์„ฑ, ์˜์ธ์„ฑ(surgical removal)
  • ๋ถ€๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ์ด ๋‚˜์˜ค์ง€ ์•Š์œผ๋ฉด โ†’ ํ˜ˆ์ค‘ ์นผ์Š˜ ๋†๋„๊ฐ€ ๋–จ์–ด์ง€๊ณ , hypocalcemia โ†’ ๊ทผ์œก์˜ ๋–จ๋ฆผ, ๊ฒฝ์ง, ๋ฐœ์ž‘ (๋Œ€ํ‘œ์ ์œผ๋กœ ๊ทผ์œก, ์‹ ๊ฒฝ ๊ด€๋ จ ์ฆ์ƒ)
  • milk fever (parturient hypocalcemia) : ๋ถ„๋งŒ ํ›„ lactation์ด ์‹œ์ž‘๋˜๋ฉด์„œ ์นผ์Š˜ ์š”๊ตฌ๋Ÿ‰์ด ๋งค์šฐ ๋†’์•„์ง„๋‹ค. ์ •์ƒ์ ์œผ๋กœ ๋ณด์ƒํ•ด์ฃผ์ง€ ๋ชปํ•˜๋ฉด ์นผ์Š˜์ด ๋‹ค ์†Œ๋ชจ๋˜์–ด ๊ธ‰์„ฑ์œผ๋กœ hypocalcemia.
  • ์ž„์ƒ ์ฆ์ƒ : ๊ทผ์œก ์œ„์ถ•, recumbency, ์ถ”์œ„๋ฅผ ๊ฒฌ๋””์ง€ ๋ชปํ•จ
  • ์น˜๋ฃŒ : IV๋กœ ์นผ์Š˜ ๋ณด์ถฉ (๋น ๋ฅธ ์น˜๋ฃŒ)

4๏ธโƒฃ Adrenal Gland (๋ถ€์‹ )

Normal Structure & Hormone Production


๋ถ€์‹ ์˜ ๋‹จ๋ฉด. Cortex (zona granulosa, zona fasciculata,zona reticularis)์™€ Medulla๋กœ ์ด๋ฃจ์–ด์ ธ ์žˆ๋‹ค. & Adrenal cortex์™€ medulla์—์„œ ๋ถ„๋น„๋˜๋Š” ํ˜ธ๋ฅด๋ชฌ ๋ชจ์‹๋„.

  • Cortex(ํ”ผ์งˆ)๊ณผ Medulla(์ˆ˜์งˆ)๋กœ ๊ตฌ์„ฑ
  • ํ”ผ์งˆ
    • Zona glomerulosa โ†’ Aldosterone (mineralocorticoid)****
    • Zona fasciculata โ†’ Cortisol (glucocorticoid)
    • Zona reticularis โ†’ Androgen
  • Medulla :
    • Tyrosine โ†’ Norepinephrine, Epinephrine

๋ถ€์‹  ์งˆํ™˜์„ ๋ณผ ๋•Œ๋Š” ์–ด๋–ค layer์˜ ๋ฌธ์ œ์ธ์ง€ ์ƒ๊ฐํ•ด์•ผ ํ•œ๋‹ค. ์ „ํ•ด์งˆ ๋ฌธ์ œ๋ฉด glomerulosa, cortisol ๋ฌธ์ œ๋ผ๋ฉด fasciculalta.. ํ˜„์ƒ๊ณผ ๋ณ‘๋ฆฌํ•™์  ๋ณ€ํ™”๋ฅผ ์—ฐ๊ฒฐ์‹œํ‚ค๋Š” ์—ฐ์Šต์„ ํ•˜์ž.


Mineralocorticoid๋ฅผ ์กฐ์ ˆํ•˜๋Š” RAAS system๊ณผ glulcocorticoid๋ฅผ ์กฐ์ ˆํ•˜๋Š” HPA axis.

  • ํŠนํžˆ zona glomerulosa์—์„œ ๋ถ„๋น„๋˜๋Š” aldosterone์€ HPA axis๋ณด๋‹ค๋Š” RAAS ์‹œ์Šคํ…œ์— ์˜ํ•ด ์กฐ์ ˆ๋œ๋‹ค๊ณ  ๋ฐฐ์› ๋‹ค.
    • Juxtaglomerular complex์—์„œ ์‹ ์žฅ์œผ๋กœ ์œ ์ž…๋˜๋Š” ํ˜ˆ๋ฅ˜๋Ÿ‰ ๋ณ€ํ™”๋ฅผ ๊ฐ์ง€ โ†’ Macula densa์—์„œ renin ๋ถ„๋น„ โ†’ Angiotension-Aldosterone ์ถ•์„ ์ญ‰ ์ž๊ทนํ•ด์„œ aldosterone์ด ๋งŽ์ด ๋ถ„๋น„๋จ โ†’ systemicํ•˜๊ฒŒ ์ฒด์•ก๋Ÿ‰ ์กฐ์ ˆ
  • zona fasciculata, zona reticularis์—์„œ ๋ถ„๋น„ํ•˜๋Š” ํ˜ธ๋ฅด๋ชฌ์€ HPA (Hypothalamic-Pituitary-Adrenocortical) axis์— ์˜ํ•ด ์ฃผ๋กœ ์กฐ์ ˆ๋œ๋‹ค.
    • ์‹œ์ƒํ•˜๋ถ€์—์„œ CRH โ†’ ๋‡Œํ•˜์ˆ˜์ฒด์—์„œ ACTH โ†’ ๋ถ€์‹ ์—์„œ cortisol
  • ์ด๋Ÿฐ๊ฒƒ์„ ์•Œ๊ณ  ์žˆ์–ด์•ผ ๋ฌธ์ œ๊ฐ€ ์ƒ๊ธด ๋ถ€์œ„๋ฅผ ์ถ”์ธกํ•  ์ˆ˜ ์žˆ๋‹ค. (Cortex ์ „์ฒด๊ฐ€ ํŒŒ๊ดด๋  ๋•Œ, ACTH ๋ฌธ์ œ์ผ ๋•Œ ์˜ํ–ฅ์„ ๋ฐ›๋Š” ํ˜ธ๋ฅด๋ชฌ์˜ ๋ฒ”์œ„๊ฐ€ ๋‹ค๋ฅด๊ณ , aldosterone์€ RAAS์— ์˜ํ•ด ์กฐ์ ˆ๋˜๋ฏ€๋กœ ๋น„๊ต์  ์ •์ƒ์ ์œผ๋กœ ์œ ์ง€๋  ์ˆ˜ ์žˆ๋‹ค)
4.1 Hyperadrenocorticism (Cushingโ€™s Syndrome)

ํฌ๊ฒŒ 3๊ฐ€์ง€ ํ˜•ํƒœ๋กœ ๋‚˜๋ˆŒ ์ˆ˜ ์žˆ๋‹ค.

  • (1) Pituitary-dependent (PDH) : functional corticotroph adenoma โ†’ ACTH ๊ณผ๋‹ค ๋ถ„๋น„ โ†’ ์–‘์ธก ๋ถ€์‹ ํ”ผ์งˆ ๋น„๋Œ€

  • (2) Adrenal-dependent (ADH) : cortisol-producing adenoma/carcinoma ๋ถ€์‹  ํ”ผ์งˆ์˜ adenoma, carcinoma๊ฐ€ ์ž์œ ๋กญ๊ฒŒ ๋ถ„๋น„ โ†’ cortisol ์ฆ๊ฐ€ โ†’ negative feedback์œผ๋กœ ACTH ๊ฐ์†Œ โ†’ ์ข…์–‘ ์—†๋Š” ๋ถ€์œ„๋Š” ์œ„์ถ•๋จ.

    • (๊ฐ‘์ƒ์„ ์—์„œ๋Š” carcinoma๋Š” ์ฃผ๋กœ non-functionalํ–ˆ๋Š”๋ฐ, ๋ถ€์‹ ์—์„œ๋Š” carcinoma๋„ functionalํ•  ์ˆ˜ ์žˆ๋‹ค๋Š” ์ ์ด ์ฐจ์ด)
  • (3) Iatrogenic : ์žฅ๊ธฐ๊ฐ„ glucocorticoid ํˆฌ์—ฌ โ†’ ACTH ๊ฐ์†Œ โ†’ ๋ถ€์‹ ํ”ผ์งˆ ์œ„์ถ•

    Adrenocortical atrophy. Cortex๊ฐ€ ์—„์ฒญ ์ˆ˜์ถ•ํ•œ ๊ฒƒ์„ ๋ณผ ์ˆ˜ ์žˆ๋‹ค.

  • ์ž„์ƒ์ ์œผ๋กœ ๋‹ค์Œ๊ณผ ๊ฐ™์€ ์†Œ๊ฒฌ์ด ๋‚˜ํƒ€๋‚œ๋‹ค.

    • PU/PD, polyphagia, alopecia
    • pendulous abdomen, muscle wasting โ†’ ๊ทผ์œก์ด ์œ„์ถ•๋˜๊ณ  ํ”ผ๋ถ€๊ฐ€ ์–‡์•„์ง€๋ฉด์„œ pot belly ์ฆ์ƒ
    • ๋ฉด์—ญ ๋ฐ˜์‘์ด๋‚˜ ์—ผ์ฆ ๋ฐ˜์‘์ด ๋งค์šฐ ์–ต์ œ๋˜๊ณ , fibroblast ์ฆ์‹๊ณผ wound healing ๊ณผ์ •๋„ ์–ต์ œ๋œ๋‹ค. โ†’ ๋ด‰ํ•ฉ๋œ ๋ถ€๋ถ„์ด ์ž˜ ์น˜์œ ๋˜์ง€ ์•Š๊ณ , ๊ฐ์—ผ์—๋„ ์ทจ์•ฝํ•˜๋‹ค.
    • Calcinosis cutis(ํ”ผ๋ถ€ ์ „๋ฐ˜์ ์ธ ์นผ์Š˜ ์นจ์ฐฉ)
    • Hepatomeglay (๊ฐ„๋น„๋Œ€) : ๊ฐ„์— glycogen์ด ์นจ์ฐฉ๋˜๋ฉด์„œ vacuolization โ†’ ๊ฐ„์ด ์ „๋ฐ˜์ ์œผ๋กœ ์ปค์ง€๊ณ  yellowish
  • ์กฐ์งํ•™์ ์œผ๋กœ๋Š” form์— ๋”ฐ๋ผ ๋‹ค๋ฅด๋‹ค.

    • Pituitary-dependent โ†’ ๋ถ€์‹  ํ”ผ์งˆ์˜ ์–‘์ธก์„ฑ ๋น„๋Œ€
    • Adrenal-dependent โ†’ ํ•œ ์ชฝ์€ ์ข…์–‘์ด๋‚˜ ์ฆ์‹์„ฑ ๋ณ‘๋ณ€, ๋ฐ˜๋Œ€ํŽธ์€ ์œ„์ถ•
    • Iatrogenic โ†’ ACTH ๊ฐ์†Œ, ๋ถ€์‹  ํ”ผ์งˆ์˜ ์–‘์ธก์„ฑ ์œ„์ถ•


Nodular adrenocortical hyperplasia.

4.2 Hypoadrenocorticism (Addisonโ€™s Disease)

๋ฉด์—ญ ๋งค๊ฐœ์„ฑ์œผ๋กœ ๋ถ€์‹  ํ”ผ์งˆ(๋ชจ๋“  ์ธต)์ด ํŒŒ๊ดด๋˜๋Š” ์งˆํ™˜. (๊ฐœ์˜ hypothyroidism์—์„œ ๋ฉด์—ญ๋งค๊ฐœ์„ฑ์œผ๋กœ ๊ฐ‘์ƒ์„  ํŒŒ๊ดด๊ฐ€ ์ผ์–ด๋‚˜๋Š” ๊ฒƒ๊ณผ ๋น„์Šทํ•˜๋‹ค)

  • Cortisol, aldosterone์ด ๋ชจ๋‘ ๊ฒฐํ•.
    • Cortisol ๊ฒฐํ• โ†’ ์ŠคํŠธ๋ ˆ์Šค ๋Œ€์‘ ๋Šฅ๋ ฅ์ด ๋–จ์–ด์ง„๋‹ค.
    • Aldosterone ๊ฒฐํ• โ†’ (์›๋ž˜ sodium์„ ์œ ์ง€ํ•˜๊ณ  potassium์„ ๋‚ด๋ณด๋‚ด์•ผ ํ•˜๋Š”๋ฐ) hyponatremia, hyperkalemia โ†’ bradycardia, ๊ตฌํ† /์„ค์‚ฌ ๋“ฑ ์†Œํ™”๊ธฐ ์ฆ์ƒ
  • episodic collapse


๋ถ€์‹  ํ”ผ์งˆ์˜ ์—ผ์ฆ๊ณผ ์œ„์ถ• (Lymphoplasmacytic adrenalitis with adrenocortical atrophy). Addisonโ€™s disease์˜ ํŠน์ง• - ํ”ผ์งˆ์˜ ์„ธ ์ธต์ด ์‹ฌํ•˜๊ฒŒ ์œ„์ถ•๋˜์–ด ์žˆ๋‹ค. (C) ๊ฑฐ์˜ ๋ชจ๋“  ํ”ผ์งˆ ์„ธํฌ๊ฐ€ ํŒŒ๊ดด๋จ.

4.3 Pheochromocytoma
  • ๋ถ€์‹  ์ˆ˜์งˆ์— ์ƒ๊ธด ์ข…์–‘, ๊ฐœ์™€ ํŽ˜๋ ›์—์„œ ๋งŽ์ด ๋ณด์ธ๋‹ค.
  • catecholamines(epinephrine/norepinephrine)์„ ๋งŒ๋“ค ์ˆ˜ ์žˆ๋‹ค.
  • ์ž„์ƒ ์ฆ์ƒ : episodicํ•˜๊ฒŒ(์ฃผ๊ธฐ์ ์œผ๋กœ) ๋‚˜ํƒ€๋‚˜๋Š” ๊ฒƒ์ด ํŠน์ง•์ด๋‹ค.
    • episodic hypertension, tachycardia, panting (functional ์ข…์–‘์ด๋‹ค)
  • ์œก์•ˆ์ ์œผ๋กœ๋Š” unilateral adrenal mass๊ฐ€ ๊ด€์ฐฐ๋˜๊ณ , ์•ฝ๊ฐ„ red-brown ์ƒ‰์„ ๋ค๋‹ค. Vena cava๋ฅผ ์นจ์Šตํ•  ์ˆ˜ ์žˆ๋‹ค๋Š” ์ ์—์„œ ์•…์„ฑ์˜ ํ˜•ํƒœ๋ฅผ ๋ ๋Š” ๊ฒฝ์šฐ๊ฐ€ ์žˆ๋‹ค!!
  • ์กฐ์งํ•™์ ์œผ๋กœ๋Š” ๋‹ค๊ฐํ˜• ์„ธํฌ๊ฐ€ nest ํ˜•ํƒœ๋กœ ์กด์žฌ(๋‚ด๋ถ„๋น„ ๊ณ„ํ†ต์˜ ์ „๋ฐ˜์ ์ธ ํŠน์ง•), ๊ณผ๋ฆฝ์–‘์ƒ(abundant granular cytoplasm)
  • ์ง„๋‹จ์„ ์œ„ํ•ด ์†Œ๋ณ€์—์„œ metanephrines(catecholamine์˜ ๋Œ€์‚ฌ์ฒด) ๋†๋„๋ฅผ ์ธก์ •ํ•  ์ˆ˜ ์žˆ๋‹ค.

5๏ธโƒฃ Pancreatic Islets (์ด์ž์„ฌ)

์ด์ž๋Š” exocrine pancreatic, endocrine pancreas (pancreatic islet)๋กœ ๋‚˜๋ˆŒ ์ˆ˜ ์žˆ๋‹ค.

  • Endocrine pancreas๋Š” ๋‹ค์Œ ์„ธํฌ๋กœ ๊ตฌ์„ฑ๋œ๋‹ค.

    • ฮฒ-cells (insulin ๋ถ„๋น„)
    • ฮฑ-cells (glucagon ๋ถ„๋น„)
    • ฮด-cells (somatostatin ๋ถ„๋น„)
    • PP cell (pancreatic polypeptide ๋ถ„๋น„)
  • ์ธ์А๋ฆฐ โ†’ glucose๋ฅผ glucogen ํ˜•ํƒœ๋กœ ์ €์žฅ, ํ˜ˆ๋‹น์„ ๋‚ฎ์ถ˜๋‹ค (๋ง์ดˆ ์กฐ์ง์—์„œ ํก์ˆ˜/์ €์žฅ)

  • ๊ธ€๋ฃจ์นด๊ณค โ†’ glucogen์„ glucose๋กœ ๋ถ„ํ•ด, ํ˜ˆ๋‹น์„ ๋†’์ธ๋‹ค (glycogenolysis/gluconeogenesis)

  • ๋”ฐ๋ผ์„œ ์ทŒ์žฅ์˜ ๋‚ด๋ถ„๋น„ ์งˆํ™˜ โ†’ ํ˜ˆ๋‹น ์ฒดํฌ๊ฐ€ ์ฒซ ๋ฒˆ์งธ! (ํ˜ˆ๋‹น์ด ๋†’์œผ๋ฉด ๋‹น๋‡จ, ํ˜ˆ๋‹น์ด ๋‚ฎ์œผ๋ฉด insulinoma.. ์ด๋ ‡๊ฒŒ)

5.1 Diabetes Mellitus

[ in Dogs ]

  • ๊ฐœ์˜ ๊ฒฝ์šฐ type 1(insulin-dependent) ์ด ๋งŽ๋‹ค. ์›์ธ์€ ๋ฉด์—ญ๋งค๊ฐœ์„ฑ์œผ๋กœ ฮฒ cell์ด ํŒŒ๊ดด๋œ ๊ฒƒ.
  • ฮฒ cell ํŒŒ๊ดด์™€ ์ทŒ์žฅ์˜ ์—ผ์ฆ์ด ํŠน์ง•์ด๋‹ค.
  • ์ค‘๋…„๋ น~๋…ธ๋ น, ์ˆ˜์ปท๋ณด๋‹ค ์•”์ปท์˜ ๊ฐœ์—์„œ ๋งŽ์ด ๋‚˜ํƒ€๋‚œ๋‹ค.
  • ์ฆ์ƒ : ๋‹ค์Œ/๋‹ค๋‡จ, ๋‹ค์‹, ์ฒด์ค‘ ๊ฐ์†Œ, ๋‹น๋‡จ์„ฑ ๋ฐฑ๋‚ด์žฅ(cataracts)
    • ํ˜ˆ๋‹น์€ ๋†’์ง€๋งŒ glucose๊ฐ€ ์„ธํฌ๋‚ด๋กœ ๋“ค์–ด๊ฐ€์ง€ ๋ชปํ•ด์„œ, ๋งŽ์ด ๋จน์–ด๋„ ์ฒด์ค‘์ด ๊ฐ์†Œํ•œ๋‹ค.,
  • ์กฐ์งํ•™์  ์†Œ๊ฒฌ : iselet ์˜ number/size โ†“, lymphocytic infiltration(์ฃผ์œ„์— ์—ผ์ฆ์„ธํฌ ์นจ์œค), ฮฒ cell์˜ ๊ณตํฌ์™€ ๋ณ€์„ฑ


Chronic pancreatitis, dog.

[ in Cats ]

  • ๊ณ ์–‘์ด์—์„œ๋Š” type 2(insulin์— ๋ฐ˜์‘ํ•˜์ง€ ์•Š์Œ) ๊ฐ€ ๋งŽ๋‹ค.
  • ๊ณผ์ฒด์ค‘ ํ˜น์€ ๋‚˜์ด๋“  ์ˆ˜์ปท ๊ณ ์–‘์ด์—์„œ ๋งŽ๋‹ค.
  • ์ž„์ƒ ์ฆ์ƒ์€ ๋น„์Šทํ•˜๋‹ค(PU/PD, ๋‹ค์‹ but ์ฒด์ค‘๊ฐ์†Œ) + ๋‹น๋‡จ์„ฑ ์‹ ๊ฒฝ๋ณ‘์ฆ(diabetic neuropathy)
  • ๋ณ‘์ธ : (์ธ์А๋ฆฐ ๋ถ„๋น„๋Š” ๊ณ„์† ๋˜์ง€๋งŒ ๋ฐ˜์‘X) hyperglycemia๊ฐ€ ์ง€์† โ†’ ฮฒ cell ๋ถ€๋‹ด ๊ณผ์ค‘


Pancreatic islets, cat - Hydropic degeneration.

5.2 Insulinoma (ฮฒ-cell Tumor)
  • ๊ฐœ์™€ ํŽ˜๋ ›์—์„œ ๊ด€์ฐฐ๋˜๋Š” ๊ฐ€์žฅ ํ”ํ•œ ์ข…๋ฅ˜์˜ islet cell tumor, funcitonal tumor์ด๋‹ค.
  • ์ธ์А๋ฆฐ์„ ๊ณผ๋„ํ•˜๊ฒŒ ๋ถ„๋น„ โ†’ glucose ๋†๋„๊ฐ€ ๊ณ„์† ๋‚ฎ์•„์ง„๋‹ค.
  • ํ˜ˆ๋‹น์ด ์ง€์†์ ์œผ๋กœ ๋‚ฎ์•„์ ธ ์žˆ์œผ๋ฉด(recurrent hypoglycemia) ๊ฐ€์žฅ ๋จผ์ € ์‹ ๊ฒฝ๊ณ„๊ฐ€ ์˜ํ–ฅ์„ ๋งŽ์ด ๋ฐ›๋Š”๋‹ค.
    • ํ—ˆ์•ฝ, ๊ธฐ๋ฆฝ ๋ถˆ๋Šฅ, ๋ฐœ์ž‘
  • ์œก์•ˆ ์†Œ๊ฒฌ : ์ž‘๊ณ  paleํ•œ pancreatic nodule์ด ๊ด€์ฐฐ๋œ๋‹ค. (ํ˜น์€ ์™ธ๋ถ„๋น„์ทŒ์žฅ์„ ๋‹ค ๋ฐ€์–ด๋‚ด๋ฉด์„œ ํฌ๊ฒŒ ์ž๋ž„ ์ˆ˜๋„ ์žˆ๋‹ค)
  • ์—ฌ๊ธฐ์„œ๋„ nest๋ฅผ ์ด๋ฃจ๋Š” ๋‚ด๋ถ„๋น„ ์„ธํฌ + ์„ธํฌ์งˆ ๊ณผ๋ฆฝํ™”๊ฐ€ ๊ด€์ฐฐ๋œ๋‹ค.


ฮฒ-cell adenoma & carcinoma.

5.3 Rare Islet Cell Tumors
  • Gastrinoma : ์œ„์—์„œ gastrin์„ ๋ถ„๋น„ํ•˜๋Š” ๋‚ด๋ถ„๋น„ ์„ธํฌ๋“ค์˜ ์ข…์–‘์„ฑ ์ฆ์‹ โ†’ gastrin์˜ ๊ณผ๋‹ค ๋ถ„๋น„ โ†’ ์œ„์˜ ์‚ฐ๋„๋ฅผ ๋†’์ž„(Hyperacidity, ์‚ฐ์„ฑ๋„๊ฐ€ ์„ธ์ง). โ†’ ๊ถค์–‘์œผ๋กœ ๋‚˜ํƒ€๋‚จ.
    • ์ด ์ผ๋ จ์˜ ๊ณผ์ •์„ Zollinger-Ellison Syndrome ์ด๋ผ๊ณ ๋„ ๋ถ€๋ฅธ๋‹ค. (์ด๋ ‡๊ฒŒ ์ƒ๊ธฐ๋Š” ์‹ฌ๊ฐํ•œ ์œ„๊ถค์–‘)
  • Somatostatinoma, PPomas๋Š” ์ข…์–‘์ด ๋  ์ˆ˜ ์žˆ๋‹ค๊ณ  ์ฑ…์—๋Š” ์žˆ์ง€๋งŒ ๊ต‰์žฅํžˆ ๋“œ๋ฌผ๋‹ค.

6๏ธโƒฃ Others

6.1 Endocrine Paraneoplastic Syndromes
  • Humoral Hypercalcemia of Malignancy (HHM, ์•…์„ฑ ๊ณ ์นผ์Š˜ํ˜ˆ์ฆ) :
    • ์ข…์–‘์„ธํฌ๊ฐ€ PTHrP(PTH-related peptide)๋ฅผ ์ž์œจ์ ์œผ๋กœ ๋ถ„๋น„ํ•ด์„œ, ๋ผˆ์˜ ์นผ์Š˜ ํก์ˆ˜์™€ ์‹ ์žฅ์˜ ์นผ์Š˜ ์žฌํก์ˆ˜๊ฐ€ ์ด‰์ง„๋˜์–ด hypercalcemia๊ฐ€ ์œ ๋ฐœ๋œ๋‹ค. feedback์œผ๋กœ ์ธํ•ด ์‹ค์ œ PTH ์ˆ˜์น˜๋Š” ๋‚ฎ๋‹ค.
    • ํ•ด๋‹นํ•˜๋Š” ์ข…์–‘์œผ๋กœ apocrine gland anal sac adenocarcinoma(๊ฐœ์˜ ํ•ญ๋ฌธ๋‚ญ ์„ ์•”์ข…), lymphoma(๊ฐœ/๊ณ ์–‘์ด ๋ฆผํ”„์ข…) 2๊ฐœ๋Š” ๊ผญ ๊ธฐ์–ตํ•ด์•ผ ํ•œ๋‹ค.
  • SIADH-like Syndrome :
    • [Syndrome of Inappropriate Antidiuretic Hormone Secretion, ๋ถ€์ ์ ˆ ํ•ญ์ด๋‡จํ˜ธ๋ฅด๋ชฌ ๋ถ„๋น„ ์ฆํ›„๊ตฐ]๊ณผ ์œ ์‚ฌํ•œ ์ƒํƒœ
    • SIADH : ADH๊ฐ€ ๋น„์ •์ƒ์ ์œผ๋กœ ๊ณผ๋„ํ•˜๊ฒŒ ๋ถ„๋น„๋˜์–ด ๋ฌผ์˜ ์žฌํก์ˆ˜๊ฐ€ ์ฆ๊ฐ€, water retention
    • ์ข…์–‘์„ธํฌ๊ฐ€ ADH ๋˜๋Š” ADH ์œ ์‚ฌ ๋ฌผ์งˆ์„ ๋ถ„๋น„ํ•ด์„œ ๊ฐ™์€ ๊ฒฐ๊ณผ๋ฅผ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค.
  • Cushingโ€™s-like Syndrome : ๋‹ค๋ฅธ ์žฅ๊ธฐ์—์„œ ectopicํ•˜๊ฒŒ ACTH ๋ถ„๋น„, ๋™๋ฌผ์—์„œ๋Š” rare
  • Carcinoma, lymphoma, apocrine gland tumors์— ์˜ํ•ด ๋‚ด๋ถ„๋น„๊ณ„ ๊ต๋ž€์ด ์ผ์–ด๋‚  ์ˆ˜ ์žˆ๋‹ค.
6.2 Chemodectoma (Aortic Body Tumor)
  • Heart base tumor์—์„œ ์ฒซ ๋ฒˆ์งธ๋กœ ๊ผฝํžˆ๋Š” ์ค‘์š”ํ•œ ์ข…์–‘.
  • Aortic body (๋˜๋Š” ๋“œ๋ฌผ๊ฐœ carotid body)์˜ paraganglia์—์„œ ์œ ๋ž˜ํ•œ๋‹ค.
  • Brachycephalic(๋‹จ๋‘์ข…)์—์„œ ๋น„๊ต์  ํ”ํ•˜๋‹ค - Boxers, Boston Terriers ๋“ฑ
  • nonfunctionalํ•˜์ง€๋งŒ locally invasive: ๊ธฐ๋Šฅ์ ์ด์ง„ ์•Š์ง€๋งŒ ํฌ๊ธฐ๊ฐ€ ์ปค์ง์œผ๋กœ์จ ๋ฌธ์ œ๋ฅผ ๋งŒ๋“ ๋‹ค.
  • Heart base ๊ทผ์ฒ˜์—์„œ ํšŒ์ƒ‰๋น›์„ ๋ ๋Š” ๋‹จ๋‹จํ•œ mass, ์กฐ์งํ•™์ ์œผ๋กœ๋Š” ์ „ํ˜•์ ์ธ ๋‚ด๋ถ„๋น„ ํŒจํ„ด(nest of round cells)

DDx: Ectopic thyroid tumor

  • Heart base tumor โ†’ chemodectoma ์™ธ์— ectopic thyroid tumor, hemangiosarcoma
  • Hemangiosarcoma๋Š” ์ƒ‰๊น”๋ถ€ํ„ฐ ์งˆ๊ฐ๊นŒ์ง€ ํ‹ฐ๊ฐ€ ๋‚œ๋‹ค. ํ•˜์ง€๋งŒ ectopic thyroid tumor๋Š” ํ—ท๊ฐˆ๋ฆด ์ˆ˜ ์žˆ์Œ.
  • Ectopic thyroid carcinoma๋Š” aorta๋‚˜ pulmonary trunk ์ฃผ๋ณ€์„ ๋‘˜๋Ÿฌ์‹ธ๊ณ  right atrium ์ชฝ์œผ๋กœ ๋Œ์ถœ๋  ์ˆ˜ ์žˆ๋‹ค.
  • ์œก์•ˆ์œผ๋กœ๋Š” ๊ฐ๋ณ„ํ•  ์ˆ˜ ์—†๋‹ค, ์ •๋ฐ€ ๊ฒ€์‚ฌ๊ฐ€ ํ•„์š” โ†’ Thyroglobulin์— ๋Œ€ํ•ด ๋ฉด์—ญ์—ผ์ƒ‰์œผ๋กœ ๊ฐ๋ณ„(๋ฐœํ˜„=ectopic thyroid tumor) + chemodectoma ํŠน์ง•์ ์ธ ๋‹จ๋ฐฑ์งˆ ๊ฒ€์‚ฌ


Summary

AI๊ฐ€ ๋‹ค๋“ฌ์–ด์คฌ๊ณ  ๋‹ค์‹œ ํ• ์ง€๋Š” ๊ธ€์Ž„..

๐Ÿ• Dog (๊ฐœ)
  • ๋‹ค๋ฐœ ์งˆํ™˜: Hypothyroidism, Hyperadrenocorticism, Diabetes Mellitus (Type I), Insulinoma, Addisonโ€™s disease, Parathyroid adenoma.
  • ๋ณ‘๋ฆฌํ•™์  ํŠน์ง•
    • Hypothyroidism (๊ฐ‘์ƒ์„  ๊ธฐ๋Šฅ ์ €ํ•˜์ฆ): ์ฃผ๋กœ ๋ฉด์—ญ ๋งค๊ฐœ์„ฑ(Lymphocytic thyroiditis) ๊ธฐ์ „์œผ๋กœ ๋ฐœ์ƒ. ์กฐ์งํ•™์ ์œผ๋กœ ๋ฆผํ”„๊ตฌ์™€ ํ”Œ๋ผ์ฆˆ๋งˆ ์„ธํฌ ์นจ์œค์— ์˜ํ•œ ์—ฌํฌ ํŒŒ๊ดด ๋ฐ ์œ„์ถ•์ด ํŠน์ง•์ž„. ์ž„์ƒ์ ์œผ๋กœ ๋ฌด๊ธฐ๋ ฅ, ๋น„๋งŒ, ์–‘์ธก ๋Œ€์นญ์„ฑ ํƒˆ๋ชจ๊ฐ€ ๋‚˜ํƒ€๋‚จ. (โ€ป ํƒˆ๋ชจ์™€ ๋ฌด๊ธฐ๋ ฅ์€ ํƒ€ ๋‚ด๋ถ„๋น„ ์งˆํ™˜๊ณผ ์†Œ๊ฒฌ์ด ๊ฒน์น˜๋ฏ€๋กœ ์กฐ์ง ์†Œ๊ฒฌ๊ณผ ๋ฐ˜๋“œ์‹œ ๋งค์นญํ•ด์•ผ ํ•จ).
    • Addisonโ€™s disease (์—๋””์Šจ๋ณ‘): ๊ฐœ์˜ ๋ฉด์—ญ๋งค๊ฐœ์„ฑ ๊ฐ‘์ƒ์„ ์—ผ๊ณผ ์œ ์‚ฌํ•˜๊ฒŒ ๋ฉด์—ญ ๋งค๊ฐœ์„ฑ ๋ถ€์‹ ์—ผ(Adrenalitis)์— ์˜ํ•ด ํ”ผ์งˆ ์ „์ฒด๊ฐ€ ํŒŒ๊ดด๋˜๋Š” ๊ธฐ๋Šฅ ์ €ํ•˜์ฆ์ž„. ํ˜ธ๋ฅด๋ชฌ ์ถ•(HPA Axis)์˜ ํŒŒ๊ดด ํ˜„์ƒ๊ณผ ์—ฐ๊ฒฐํ•˜์—ฌ ์ดํ•ดํ•ด์•ผ ํ•จ.
๐Ÿˆ Cat (๊ณ ์–‘์ด)
  • ๋‹ค๋ฐœ ์งˆํ™˜: Hyperthyroidism, Diabetes Mellitus (Type II), Hypersomatotropism.
  • ๋ณ‘๋ฆฌํ•™์  ํŠน์ง•
    • Hyperthyroidism (๊ฐ‘์ƒ์„  ๊ธฐ๋Šฅ ํ•ญ์ง„์ฆ): ์ฃผ๋กœ ๊ธฐ๋Šฅ์„ฑ ๊ฐ‘์ƒ์„  ํ”ผ์งˆ ๊ณผ์ฆ์‹(Hyperplasia) ๋˜๋Š” ์–‘์„ฑ ์„ ์ข…(Adenoma)์— ์˜ํ•ด ํ˜ธ๋ฅด๋ชฌ์ด ์ž์œจ์ ์œผ๋กœ ๊ณผ๋‹ค ๋ถ„๋น„๋จ.
    • Diabetes Mellitus (๋‹น๋‡จ๋ณ‘): ๊ฐœ์™€ ๋‹ฌ๋ฆฌ ์ฃผ๋กœ Type II (์ธ์А๋ฆฐ ์ €ํ•ญ์„ฑ) ํ˜•ํƒœ์ž„. ์ทŒ์žฅ ๋‚ด๋ถ„๋น„๋ถ€ Islet ์„ธํฌ์— ์•„๋ฐ€๋กœ์ด๋“œ ์นจ์ฐฉ(Islet amyloidosis) ๋ฐ ์ˆ˜์ข…์„ฑ ๋ณ€์„ฑ์ด ๋™๋ฐ˜๋˜๋Š” ๊ธฐ์ „์  ์ฐจ์ด๊ฐ€ ์ค‘์š”ํ•จ.
    • ๊ธฐํƒ€ ํŠน์ง•: ์ดˆ๊ธฐ ์ž„์ƒ ์†Œ๊ฒฌ์ด ๋ฏธ์•ฝํ•˜๋ฉฐ, ๊ฐœ์— ๋น„ํ•ด ์‹ฌ๊ฐํ•œ ๋Œ€์‚ฌ์  ์ด์ƒ ์ˆ˜์น˜์— ๋Œ€ํ•œ ๋Œ€์‚ฌ ๋‚ด์„ฑ์ด ์ƒ๋Œ€์ ์œผ๋กœ ๋†’์Œ.
๐Ÿ‚ Ruminants (๋ฐ˜์ถ”์ˆ˜)
  • Goiter (๊ฐ‘์ƒ์„ ์ข…): ๋ฐ˜์ถ”๋ฅ˜์˜ ๊ฐ€์žฅ ๋Œ€ํ‘œ์ ์ธ ๊ฐ‘์ƒ์„  ์งˆํ™˜์œผ๋กœ, ์„ ์ฒœ์„ฑ ๊ณ ์ดํ„ฐ(Congenital goiter)๊ฐ€ ๋‹ค๋ฐœํ•จ. ๋ชจ์ฒด์˜ ์ž„์‹  ์ค‘ ์š”์˜ค๋“œ(Iodine) ๊ฒฐํ• ๋˜๋Š” ๊ฐ‘์ƒ์„ ์ข… ์œ ๋ฐœ๋ฌผ์งˆ(Goitrogens) ์„ญ์ทจ ๊ธฐ์ „์œผ๋กœ ๋ฐœ์ƒ. ์‹ ์ƒ ๊ฐ€์ถ•์—์„œ ์ „์‹  ํƒˆ๋ชจ, ํ—ˆ์•ฝ, ์กฐ์‚ฐ ๋ฐ ์‚ฌ์‚ฐ ์†Œ๊ฒฌ์„ ๋ณด์ž„.
  • Parturient Hypocalcemia (Milk fever, ์œ ์—ด): ๊ณ ์ƒ์‚ฐ์„ฑ ์ –์†Œ์—์„œ ๋ถ„๋งŒ ํ›„ ๋ณธ๊ฒฉ์ ์ธ ๋ฝํ…Œ์ด์…˜(Lactation, ์ˆ˜์œ )๊ณผ ๊ด€๋ จ๋œ ๋Œ€์‚ฌ์ƒ๋ฆฌํ•™์  ์นผ์Š˜ ๊ธ‰๊ฐ ์งˆํ™˜์ž„. ๋ถ„๋งŒ ์งํ›„ ์œ ์ฆ™ ๋ถ„๋น„๋กœ ์ธํ•œ ๊ธ‰๊ฒฉํ•œ ์นผ์Š˜ ์†Œ๋ชจ๋กœ ๋ฐœ์ƒํ•˜๋ฉฐ, ๊ทผ๋ฌด๋ ฅ ๋ฐ ๊ธฐ๋ฆฝ ๋ถˆ๋Šฅ์„ ์œ ๋ฐœํ•จ.
  • Thyroid C-cell tumors: ๋…ธ๋ น์˜ ์”จ์ˆ˜์†Œ(Bulls)์—์„œ ํ”ํ•˜๋ฉฐ, ๋ถ€์‹  ์ˆ˜์งˆ์˜ Pheochromocytoma์™€ ๋ณ‘๋ฐœํ•˜์—ฌ ๋‹ค๋ฐœ์„ฑ ๋‚ด๋ถ„๋น„์„ ์ข…(MEN-like) ์–‘์ƒ์„ ๋ณด์ž„.
๐Ÿ– Pig (๋ผ์ง€)
  • Diabetes Mellitus (๋‹น๋‡จ๋ณ‘): ๋ผ์ง€์—๊ฒŒ์„œ ์ž์—ฐ ๋ฐœ์ƒ์€ ๋งค์šฐ ๋“œ๋ฌด๋‚˜, ์‚ฌ๋žŒ ๋‹น๋‡จ๋ณ‘๊ณผ ๋ณ‘์ธ๋ก ์ (Pathogenesis)์œผ๋กœ ๋งค์šฐ ์œ ์‚ฌํ•˜์—ฌ ์˜ํ•™ ์—ฐ๊ตฌ๋ฅผ ์œ„ํ•œ ์ƒ์ฒด ์—ฐ๊ตฌ ๋ชจ๋ธ(Swine model)๋กœ ์œ ์šฉํ•˜๊ฒŒ ์‚ฌ์šฉ๋จ.
  • Goiter: ๋ฐ˜์ถ”์ˆ˜์™€ ๋™์ผํ•˜๊ฒŒ ์š”์˜ค๋“œ ๊ฒฐํ• ๋ฐ ๊ณ ์ดํ† ์   ์‹์ด์— ์˜ํ•ด ์œ ๋ฐœ๋จ.
  • ์ถ•์ข… ๊ด€๋ฆฌ์  ๊ด€์ : ๋ผ์ง€๋Š” ์ƒ์‚ฐ ๊ฐ€์ถ•(์‚ฐ์—… ๋™๋ฌผ)์ด๋ฏ€๋กœ ๊ฐœ๋ณ„ ๊ฐœ์ฒด์˜ ์ง„๋‹จ๋ณด๋‹ค๋Š” ๊ตฐ์ง‘(Herd) ์ „์ฒด์˜ ๋ฐฉ์—ญ ๋ฐ ์˜์–‘ํ•™์  ์œ„์ƒ ๊ด€๋ฆฌ๊ฐ€ ๋ณ‘๋ฆฌํ•™์ ์œผ๋กœ ๋” ์ค‘์š”ํ•จ.
๐Ÿ“ ์ด๊ด„ ๋‚ด๋ถ„๋น„ ๋ณ‘๋ฆฌํ•™ ์ง„๋‹จ Point ์ •๋ฆฌ (Summary)

๋‚ด๋ถ„๋น„ ์งˆํ™˜์€ ์‹œ์ƒํ•˜๋ถ€ - ๋‡Œํ•˜์ˆ˜์ฒด - ๋ง์ดˆ ๋‚ด๋ถ„๋น„ ์žฅ๊ธฐ ์ถ•(Axis)ํ•˜๊ณ  ํ”ผ๋“œ๋ฐฑ ๋ฃจํ”„(Feedback loop)์˜ ์ƒํ˜ธ ์œ ๊ธฐ์ ์ธ ์กฐ์ ˆ ๊ด€๊ณ„ ์‹œ์Šคํ…œ์ด๋‹ค.

1. ๊ธฐ๋Šฅ ๋ณ€ํ™”์˜ ํ˜•ํƒœ๋ณ„ ์›์ธ ์œ„์น˜ ๋ถ„๋ฅ˜
  • Hyperfunction (๊ธฐ๋Šฅ ํ•ญ์ง„์ฆ)
    • Primary (์›๋ฐœ์„ฑ): ๋‚ด๋ถ„๋น„ ์žฅ๊ธฐ ์ž์ฒด์— ๋ฐœ์ƒํ•œ Adenoma, Hyperplasia ๋˜๋Š” Carcinoma๊ฐ€ ์ƒ์œ„ ์ถ•์˜ ์กฐ์ ˆ์„ ๋ฒ—์–ด๋‚˜ ์ž์œจ์ ์œผ๋กœ ํ˜ธ๋ฅด๋ชฌ์„ ๊ณผ๋‹ค ๋ถ„๋น„. (โ€ป ์žฅ๊ธฐ๋ณ„๋กœ Carcinoma์˜ ํ˜ธ๋ฅด๋ชฌ ๊ธฐ๋Šฅ์„ฑ ํ™œ์„ฑํ™” ์œ ๋ฌด๊ฐ€ ์ƒ์ดํ•˜๋ฏ€๋กœ ๊ตฌ๋ถ„ ์š”๋ง).
    • Secondary (์†๋ฐœ์„ฑ): ๋ง์ดˆ ์žฅ๊ธฐ ์ž์ฒด์—๋Š” ๋ณ‘๋ณ€์ด ์—†์œผ๋‚˜, ์ƒ์œ„ ์žฅ๊ธฐ(๋‡Œํ•˜์ˆ˜์ฒด ๋“ฑ)์—์„œ Trophic ํ˜ธ๋ฅด๋ชฌ์ด ๊ณผ๋„ํ•˜๊ฒŒ ๋ถ„๋น„๋˜์–ด ๋ง์ดˆ ์žฅ๊ธฐ๋ฅผ ์ง€์† ์ž๊ทนํ•˜์—ฌ ๊ณผ์ฆ์‹ ์œ ๋ฐœ.
  • Hypofunction (๊ธฐ๋Šฅ ์ €ํ•˜์ฆ)
    • Primary (์›๋ฐœ์„ฑ): ๋‚ด๋ถ„๋น„ ์žฅ๊ธฐ ์ž์ฒด๊ฐ€ ๋ฉด์—ญ ๋งค๊ฐœ์„ฑ ํŒŒ๊ดด๋‚˜ ์—ผ์ฆ ๋“ฑ์— ์˜ํ•ด ์ง์ ‘ ์†์ƒ๋˜์–ด ๊ธฐ๋Šฅ ์ƒ์‹ค.
    • Secondary (์†๋ฐœ์„ฑ): ๋ง์ดˆ ์žฅ๊ธฐ๋Š” ์ •์ƒ์ด๋‚˜, ์ƒ์œ„ ์žฅ๊ธฐ(๋‡Œํ•˜์ˆ˜์ฒด/์‹œ์ƒํ•˜๋ถ€)์˜ ๋ณ‘๋ณ€(์ข…์–‘, ์™ธ์ƒ)์œผ๋กœ ์ธํ•ด ์ƒ์œ„ Trophic ํ˜ธ๋ฅด๋ชฌ ๋ถ„๋น„๊ฐ€ ๊ฒฐํ•๋˜์–ด ํ•˜์œ„ ๋ง์ดˆ ์žฅ๊ธฐ๊ฐ€ ์œ„์ถ•(Atrophy)๋จ.
  • Ectopic (์†Œ์„ฑ ํ˜ธ๋ฅด๋ชฌ ์ƒ์„ฑ): ๋‚ด๋ถ„๋น„๊ณ„์™€ ๋ฌด๊ด€ํ•œ ๊ธฐํƒ€ ์žฅ๊ธฐ์˜ ์•…์„ฑ ์ข…์–‘์ด ํ˜ธ๋ฅด๋ชฌ์„ ์†Œ์„ฑ ๋ถ„๋น„ํ•˜์—ฌ ์ „์‹  ์ถ•์„ ๊ต๋ž€ํ•จ.
2. ๋ณ‘๋ฆฌ ์ง„๋‹จํ•™์  ํ‰๊ฐ€ ๊ธฐ์ค€
  • ๋‹จ์ผ ํ˜ธ๋ฅด๋ชฌ ๋†๋„์˜ ๋‹จํŽธ์  ์ธก์ •์œผ๋กœ๋Š” ํ™•์ง„์ด ๋ถˆ๊ฐ€๋Šฅํ•˜๋ฉฐ, ์ „์ฒด Axis ์ถ•์„ ๊ด€ํ†ตํ•˜๋Š” ์ƒ์œ„ ๋ฐ ํ•˜์œ„ ํ˜ธ๋ฅด๋ชฌ์˜ ์ƒ๊ด€๊ด€๊ณ„ ์ธก์ •์ด ํ•„์ˆ˜์ ์ž„.
  • ์˜์ƒ์˜ํ•™์ (Imaging) ์žฅ๊ธฐ ํ˜•ํƒœ ํฌ๊ธฐ ์Šคํฌ๋ฆฌ๋‹๊ณผ ์ƒ๊ฒ€/๋ถ€๊ฒ€์„ ํ†ตํ•œ ์กฐ์ง๋ณ‘๋ฆฌํ•™์  ํ™•์ง„(Histopathology)์„ ์—ฐ๊ณ„ํ•˜์—ฌ ์ตœ์ข… ์ง„๋‹จํ•จ.